Zusammenfassung
Im Jahre 1962 wurde von den hervorragenden französischen Forschern Jean-Claude Dreyfus und Georges Schapira erstmalig eine Zusammenstellung und kritische Bewertung aller bis dahin bekannten biochemischen Untersuchungs-ergebnisse bei den erblichen Myopathien vorgenommen [253]. Die unter dem Titel „Biochemistry of Hereditary Myopathies“ veröffentlichte Monographie hat großes Interesse hervorgerufen und die Forschung auf diesem Gebiet wesentlich stimuliert. Seitdem hat die Zahl der Einzelbefunde außerordentlich zugenommen, wobei besonders die verschiedenen Formen der progressiven Muskeldystrophien mit einer Fülle neuer Untersuchungsergebnisse hervorragen. Zwar konnte die molekulare Genetik dieser Leiden immer noch nicht geklärt werden, doch hat die moderne biochemische Forschung einige Anhaltspunkte geliefert und die Richtung für zukünftige, möglicherweise Erfolg versprechende Untersuchungen gewiesen.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur zum Kapitel III
Abdullah, F., D. F. Goldspink, and R. J. Pennington: Ribonucleases in normal and dystrophic muscle. In: Research in Muscular Dystrophy. London: Pitman 1968, p. 312.
Acheson, D., and D. McAlpine: Muscular dystrophy associated with myoglobinuria and excessive excretion of ketosteroids. Lancet 1953 II, 372.
Acheson, J., D. C. James, E. C. Hutchinson, and R. Westhead: Serum-creatine-kinase levels in cerebral vascular disease. Lancet 1965 I, 1306.
Aebi, H.: Biochemie und Klinik einiger Enzym-Defekte. Dtsch. med. J. 13, 314 (1962).
Aebi, U., R. Richterich, H. Stillhart, J. P. Colombo, and E. Rossi: Progressive muscular dystrophy. III. Serum enzymes in muscular dystrophy in childhood. Helv. paediat. Acta 16, 543 (1961).
Aebi, U., R. Richterich, J. P. Colombo, and E. Rossi: Progressive muscular dystrophy. II. Biochemical identification of the carrier state in the recessive-sexlinked juvenile (Duchenne) type by serum creatine-phosphokinase determinations. Enzym. biol. clin. 1, 61 (1961/62).
Ahlgren, G.: Über die spontanreduzierende Einwirkung der Muskulatur auf Methylblau. Scand. Arch. Physiol. 41, 1 (1921).
Albright, E. C., F. C. Larson, and W. P. Deiss: Thyroxine binding capacity of serum alpha globulin in hypothyroid, euthyroid, and hyperthyroid subjects. J. clin. Invest. 34, 44 (1955).
Aleksakhina, N. V.: Carbohydrate-phosphate metabolism and the composition of white (breast) and red (leg) muscles of chickens. Biokhimiya 18, 513 (1953).
Allen, J. R., W. R. Beachtel, B. A. Sullivan, and H. L. Dobson: Metabolic studies in vitamin E-deficient rabbits. Metabolism 7, 646 (1958).
Allen, J. R., B. A. Sullivan, and H. L. Dobson: Cytochrome oxidase and reductase in muscle from vitamin E-deficient rabbits. Arch. Biochem. 86, 6 (1960).
Aloisi, M., A. Ascenzi ed E. Bonetti: Aspetti strutturali dell’actina studiata al microscopio elettronico nella distrofia muscolare da avitaminosi E. Experientia (Basel) 8, 266 (1952).
Ames, S. R., and H. A. Risley: Aminoaciduria in progressive muscular dystrophy. Proc. Soc. exp. Biol. (N. Y.) 68, 131 (1948).
Ames, S. R. Diskussionsbeitrag zu C. E. Roderuck: Some chemical and enzymic alterations in muscle in experimental dystrophy. Ann. N. Y. Acad. Sci. 52, 160 (1949).
Andres, R., G. Cader, and K. L. Zierler: The quantitatively minor role of carbohydrate in oxidative metabolism by skeletal muscle in intact man in the basal state. J. clin. Invest. 35, 671 (1956).
Apella, E., and C. L. Markert: Dissociation of lactate dehydrogenase into subunits with guanidine hydrochloride. Biochem. biophys. Res. Commun. 6, 171 (1961).
Armbruster, W., R. Schäfer u. K. Schaefer: Medikamentöse Beeinflussung der Aminosäureausscheidung im Urin. Schweiz. med. Wschr. 6, 147 (1957).
Aronson, S. M., and B. W. Volk: Tissue and serum aldolase in neuromuscular diseases. Arch. Neurol. Psychiat. (Chic.) 75, 568 (1956).
Aronson, S. M., and B. W. Volk Studies on serum aldolase activity in neuromuscular disorders. Amer. J. Med. 22, 414 (1957).
Aronson, S. M., and B. W. Volk Serum aldolase activity in neuromuscular disorders. 2. Experimental application. Proc. Soc. exp. Biol. (N. Y.) 94, 360 (1957).
Aronson, S. M., and B. W. Volk, A. Saifer, A. Kanof, and B. W. Volk: Progression of amaurotic family idiocy as reflected by serum and cerebrospinal fluid changes. Amer. J. Med. 24, 390 (1958).
Aronson, S. M., and B. W. Volk, G. Perle, and B. W. Volk: Studies on enzyme alterations in the infantile sphingolipidoses. Correlation with pathologic changes. Amer. J. clin. Nutr. 9, 103 (1961).
Aronson, S. M., G. Perle, A. Saifer, and B. W. Volk: Biochemical identification of the carrier state in Tay-Sachs disease. Proc. Soc. exp. Biol. (N. Y.) 111, 664 (1962).
Ashmore, C. R., and R. G. Somes Jr.: Delay of hereditary muscular dystrophy of the chicken by oxygen therapy. Proc. Soc. exp. Biol. (N. Y.) 122, 1100 (1966).
Ashmore, C. R., and R. G. Somes Jr. and F. D. Vasington: Relative distributions of myoglobin derivatives in breast muscle of chickens with hereditary muscular dystrophy. Proc. Soc. exp. Biol. (N. Y.) 122, 1104 (1966).
Askanas, W.: Immunoelectrophoretic examination of blood serum proteins in patients with neurogenic muscular atrophy. Life Sci. 5, 1517 (1966).
Askanas, W. Identification of the agent responsible for the abnormal immunoelectrophoretic pattern of serum in Duchenne’s progressive muscular dystrophy. Life Sci. 5, 1767 (1966).
Askanas, W. Immunoelectrophoretic investigations of the serum of carriers of Duchenne’s progressive muscular dystrophy. Life Sci. 5, 1775 (1966).
Askanas, W. Immunoelectrophoretic investigations of blood serum proteins in muscular diseases. J. Neurol. Neurosurg. Psychiat. 30, 43 (1967).
Asmundson, S., F. H. Kratzer, and L. M. Julian: Inherited myopathy in the chicken. Ann. N. Y. Acad. Sci. 138, 49 (1966).
Asmundson, V. S., and L. M. Julian: Inherited muscle abnormality in the domestic fowl. J. Hered. 47, 248 (1956).
Azzone, G. F., and M. Aloisi: Changes induced by E-avitaminosis on the proteins of rabbit-muscle extracts. Biochem. J. 69, 161 (1958).
Bär, U., u. M. C. Blanchaer: Glykogen and CO2 production from glucose and lactate by red and white skeletal muscle. Amer. J. Physiol. 209, 905 (1965).
Bajusz, E., and G. Jasmin: Studies on the activity and distribution of oxidative and hydrolytic enzymes in the skeletal and cardiac muscle of dystrophic mice kept on various diets. Rev. canad. Biol. 21, 409 (1962).
Bajusz, E. The “red” skeletal muscle fibers: relative independence of neural control. Life Sci. 145, 938 (1964).
Bajusz, E. Succinic dehydrogenase in muscular dystrophy. An experimental study on secondary changes resulting from disturbance in neuromuscular integrity. Exp. Med. Surg. 23, 169 (1965).
Bajusz, E., F. Homburger, J. R. Baker, and L. H. Opie: The heart muscle in muscular dystrophy with special reference to the involvement of the cardiovascular system in the hereditary myopathy of the hamster. Ann. N. Y. Acad. Sci. 138, 213 (1966).
Baker, N., M. Tubis, and W. H. Blahd: Metabolic and nutritional studies in mice with a hereditary myopathy (Dystrophia muscularis). Amer. J. Physiol. 193, 525 (1958).
Baker, N., W. H. Blahd, and P. Hart: Concentrations of K and Na in skeletal muscle of mice with a hereditary myopathy (Dystrophia muscularis). Amer. J. Physiol. 193, 530 (1958).
Baker, N., A. Bloom, and W. H. Blahd: Fatty acid peroxide-formation in tissue homogenates from mice with hereditary myopathy (Dystrophia muscularis). Amer. J. Physiol. 197, 483 (1959).
Baker, N. and R. Huebotter: Glucose metabolism and bicarbonate turnover in dystrophic mice. Amer. J. Physiol. 207, 1161 (1964).
Baker, R. D.: Uptake of alpha-aminoisobutyric acid by muscle of normal and dystrophic mice. Tex. Rep. Biol. Med. 22, Suppl. 1, 880 (1964).
Banker, B. Q.: A phase and electron microscopic study of dystrophic muscle. I. The pathological changes in the two-week-old Bar Habor 129 dystrophic mouse. J. Neuropath. exp. Neurol. 26, 259 (1967).
Banker, B. Q. and D. Denny-Brown: A study of denervated muscle in normal and dystrophic mice. J. Neuropath. exp. Neurol. 18, 517 (1959).
Barany, M., E. Gaetjens, and K. Barany: Myosin in hereditary muscular dystrophy of chickens. Ann. N.Y.Acad. Sci. 138, Art. 1, 360 (1966).
Barranco, G.: Sul comportamento della transaminasi glutammico-ossalacetia del siero di sangue nella crush syndrome; ricerche sperimentali. Arch. Sci. med. 107, 383 (1959).
Barry, T. A., and H. Rosenkrantz: The level of isocitric acid dehydrogenase in tissues of vitamin E-deficient rabbits. J. Nutr. 76, 447 (1962).
Barwick, D. D.: Investigation of the carrier state in the Duchenne type dystrophy. In: Research in Muscular Dystrophy. London: Pitman 1963, p. 10.
Basinski, D. H., and J. P. Hummel: Further observations on the succinic dehydrogenase system and the effects of tocopherol esters. J. biol. Chem. 167, 339 (1947).
Bauza, C. A.: Urinary amino acids in progressive muscular dystrophy and amyotonia congenita. Arch. Pediat. Urug. 30, 749 (1959).
Beatty, C. H., G. M. Basinger, C. C. Dully, and R. M. Bocek: Comparison of red and white voluntary skeletal muscles of several species of primates. J. Histochem. Cytochem. 14, 590 (1966).
Beatty, C. H., G. M. Basinger and R. M. Bocek: Differentation of red and white fibers in muscle from fetal, neontal and infant rhesus monkeys. J. Histochem. Cytochem. 15, 93 (1967).
Becker, P. E.: Neues zur Genetik der Myopathien. Wien. klin. Wschr. 79, 402 (1967).
Beckett, E. B., and G. H. Bourne: Some histochemical observations on human dystrophic muscle. Science 126, 357 (1957).
Beckett, E. B., and G. H. Bourne Histochemical observations on the cytochrome oxidase and succinic dehydrogenase activity of normal and diseased human muscle. Acta anat. (Basel) 33, 289 (1958).
Beckett, E. B., and G. H. Bourne 5-Nucleotidase in normal and diseased human skeletal muscle. J. Neuropath. exp. Neurol. 17, 199 (1958).
Beckett, E. B. Some applications of histochemistry to the study of skeletal muscle. Rev. canad. Biol. 21, 391 (1962).
Beckmann, R.: Therapeutische Erfahrungen bei der Behandlung der Erbschen Dystrophia musculorum progressiva mit Tocopherylphosphat und Inosit. Dtsch. Z. Nervenheilk. 167, 16 (1951).
Beckmann, R. Die kolorimetrische Serum-Vitamin-E-(Tocopherol-)Bestimmung. Int. Z. Vitamin-Forsch. 24, 393 (1952).
Beckmann, R. Muskelstoffwechsel und Muskelkrankheiten (Vitamin E, Cholin, Inosit). Münch. med. Wschr. 117, 6 (1952).
Beckmann, R. Neuere pathogenetische Betrachtungen über die Dystrophia musculorum progressiva Erb, unter besonderer Berücksichtigung der Ausscheidung an Gesamt-Neutral-C-17-Ketosteroiden. Klin. Wschr. 30, 465 (1952).
Beckmann, R. Zum Verhalten der Serumaldolaseaktivität bei Patienten mit Dystrophia musculorum progressiva Erb. Klin. Wschr. 34, 1237 (1956).
Beckmann, R. Kohlenhydratstoffwechsel, Verhalten der Fructose-1,6-diphosphat spaltenden Aldolase im Serum und funktionsbedingter Wachstumswandel der Leber beim Neugeborenen und jungen Säugling. Mschr. Kinderheilk. 107, 258 (1959).
Beckmann, R. u. C. Billich: Die Leber bei der Dystrophia musculorum progressiva Erb (Biochemische und morphologische Befunde). Med. Welt (Stuttg.) 19, 1085 (1962).
Beckmann, R. and F. Jerusalem: Male carriers of Duchenne-type muscular dystrophy? Lancet 1966 II, 1138.
Beckmann, R. u. V. v. Osten: Myoglobin und progressive Muskeldystrophie. Dtsch. med. Wschr. 91, 2267 (1966).
Beckmann, R. u. H. Ritter: Aminosäuren-Fleckenkartenbefunde bei progressiver Muskeldystrophie. Familienuntersuchungen. Dtsch. med. Wschr. 91, 2331 (1966).
Beckmann, R. Aminosäurenfleckenkartenbefunde bei progressiver Muskeldystrophie (Familienbefunde). Mschr. Kinderheilk. 115, 285 (1967).
Bell, E. T.: The interstitial granules of striated muscle and their relation. Int. Anat. Physiol. 28, 297 (1911).
Bencze, B., F. Gerloczy, M. Toth, and E. Ugrai: Quantitative changes in serum tocopherol (vitamin E) with age. Int. Z. Vitamin-Forsch. 1964, 391.
Bender, A. D., D. D. Schottelius, and B. A. Schottelius: Effect of vitamin E deficiency on protein composition of guinea pig skeletal muscle. Proc. Soc. exp. Biol. (N. Y.) 102, 362 (1959).
Benedict, J. D., M. Roche, T. F. Yu, E. J. Bien, A. B. Gutman, and D. Stetten: Incorporation of glycine nitrogen into uric acid in normal and gouty man. Metabolism 1, 3 (1952).
Benedict, J. D., H. J. Kalinsky, L. A. Scarrone, A. R. Wertheim, and D. Stetten: The origin of urinary creatine in progressive muscular dystrophy. J. clin. Invest. 34, 141 (1955).
Bengzon, A., H. Hippius u. K. Kanig: Veränderungen einiger Serumfermente während der psychiatrischen Pharmakotherapie. Dtsch. med. J. 17, 217 (1966).
Berblinger, W., u. J. Dukens: Der kardiointestinale Symptomenkomplex bei der progressiven Muskeldystrophie. 1. Klinische und pathologisch-anatomische Beobachtungen. Z. Kinderheilk. 47, 1 (1929).
Berechet, C., G. Pendefunda, C. Faighelis Si M. Ciobanu: Modificarile transaminazei si aldolazei in miopatii. Rev. méd.-chir. (Jassy) 66, 993 (1962).
Berenbaum, A. A., and W. Horrwitz: Heart involvement in progressive muscular dystrophy. Amer. Heart J. 51, 622 (1956).
Berendes, J.: Die Leistung der Kehlkopfmuskulatur unter dem Aspekt der Elektronenmikroskopie und der Enzymchemie. Mschr. Ohrenheilk. 98, 524 (1964).
Berg, L., F. G. Ebaugh, G. M. Shy, B. Horvath, and D. J. Cummings: Muscular dystrophy. Blood content of dystrophic muscles. J. appl. Physiol. 8, 31 (1953).
Berger, H.: Aminoaciduria in progressive muscular dystrophy. Rev. canad. Biol. 21, 567 (1962).
Bergman, R. A.: Observations on the morphogenesis of rat skeletal muscle. Bull. Johns Hopk. Hosp. 110, 187, 201 (1962).
Bergström, J., and E. Hultman: The effect of exercise on muscle glycogen and electrolytes in normals. Scand. J. clin. Lab. Invest. 18, 16 (1966).
Berlinguet, L., and U. Srivastava: Proteolytic enzymes in normal and dystrophic mouse muscle. Canad. J. Biochem. 44, 613 (1966).
Berni Canani, M., A. Coletta, F. Rea, and G. Fanuele: On the glucose-6-phosphate dehydrogenase and transketolase activities in the serum of subjects with progressive muscular dystrophy. Boll. Soc. ital. Biol. sper. 39, 766 (1963).
Bevans, M.: Changes in musculature of gastrointestinal tract and in myocardium in progressive muscular dystrophy. Arch. Path. 40, 225 (1945).
Bird, J. W. C., D. D. Schottelius, and B. A. Schottelius: Oxygen consumption of soleus muscles from normal, vitamin E-supplemented and vitamin E-deficient guinea pigs during rest and stimulation. Metabolism 12, 570 (1963).
Bird, J. W. C. and N. A. B. Szabo: Lipid peroxidation in nutritional muscular dystrophy. Proc. Soc. exp. Biol. (N. Y.) 117, 345 (1964).
Bird, J. W. C. and F. Carabello: Serum ATP: creatine phosphotransferase activity in guinea pigs with experimental muscular dystrophy. Nature (Lond.) 210, 95 (1966).
Biron, P., J. C. Dreyfus et F. Schapira: Différences métaboliques entre les muscles rouges et blancs chez le lapin. C. R. Soc. Biol. (Paris) 158, 1841 (1964).
Blahd, W. H., F. K. Bauer, R. L. Libby, and A. S. Rose: Radioisotope studies in neuromuscular disease. 2. Studies in muscular dystrophy and myotonia dystrophica with sodium22 and potassium42. Neurology (Minneap.) 5, 201 (1955).
Blahd, W. H., A. Bloom, and W. Drell: Qualitative study of aminoaciduria in muscular dystrophy and myotonia dystrophica. Proc. Soc. exp. Biol. (N. Y.) 90, 704 (1955).
Blahd, W. H., B. Cassen, and M. Lederer: Decreased body potassium in nondystrophic relatives of patients with muscular dystrophy. A biochemical trait. New Engl. J. Med. 270, 197 (1964).
Blahd, W. H., M. Lederer, and B. Cassen: The significance of decreased body potassium concentrations in patients with muscular dystrophy and nondystrophic relatives. New Engl. J. Med. 27, 1349 (1967).
Blanchaer, M. C., and M. Van Wijhe: Distribution of lactic dehydrogenase in skeletal muscle. Nature (Lond.) 193, 877 (1962).
Blanchaer, M. C., and M. Van Wijhe: Isoenzymes of lactic dehydrogenase in skeletal muscle. Amer. J. Physiol. 202, 827 (1962).
Blanchaer, M. C., and M. Van Wijhe and D. Mozersky: The oxidation of lactate and α-glycerophosphate by red and white skeletal muscle. I. Quantitative studies, J. Histochem. Cytochem. 11, 500 (1963).
Blanchaer, M. C., and M. Van Wijhe: Respiration of mitochondria of red and white skeletal muscle. Amer. J. Physiol. 206, 1015 (1964).
Blaxter, K. L., and W. A. Wood: Brit. J. Nutr. 6, 144 (1952).
Blietz, R. J.: Über die Behandlung der progressiven Muskeldystrophie mit Glukose-Insulin-Infusionen. Z. Orthop. 100, 211 (1965).
Blietz, R. J. Treatment of progressiv muscular dystrophy by combined infusions of glucose and insulin. Germ. med. Mth. 11, 280 (1966).
Blietz, R. J. u. F. Paulmann: Glucose-Assimilation und Insulinwirkug bei x-chromosomaler rezessiv erblicher Muskeldystrophie (Typ Duchenne) im Belastungstest. Hoppe-Seylers Z. physiol. Chem. 347, 35 (1966).
Blincoe, C., and D. W. Marble: Blood enzyme interrelationships in white muscle disease. Amer. J. vet. Res. 21, 866 (1960).
Bloor, W. R.: Effect of activity on the phospholipid and cholesterol content of muscle. J. biol. Chem. 119, 451 (1937).
Blyth, H., C. O. Carter, V. Dubowitz, A. E. H. Emery, J. Gavin, H. A. Johnston, V. A. McKusick, R. R. Race, R. Sanger, and P. Tippett: Duchenne’s muscular dystrophy and the Xg blood groups: A search for linkage. J. med. Genet. 2, 157 (1965).
Boas, E. P., and H. Lowenberg: The heart rate in progressive muscular dystrophy. Arch. intern. Med. 47, 376 (1931).
Bocek, R. M., and C. H. Beatty: Glycogen synthetase and phosphorylase in red and white muscle of rat and rhesus monkey. J. Histochem. Cytochem. 14, 549 (1966).
Bocek, R. M., R. D. Peterson, and C. H. Beatty: Glycogen metabolism in red and white muscle. Amer. J. Physiol. 210, 1101 (1966).
Böhm, P., u. L. Baumeister: Über das Vorkommen neuraminsäurehaltiger Glykoproteide in Körperflüssigkeiten. Hoppe-Seylers Z. physiol. Chem. 305, 42 (1956).
Boellner, S. W., E. J. Olson, D. Fredrickson, and E. R. Hughes: Plasma and erythrocyte magnesium in muscular dystrophy. Amer. J. Dis. Child. 110, 172 (1965).
Bois, P.: Leucine aminopeptidase activity in muscles of dystrophic mice. Experientia (Basel) 20, 140 (1964).
Bois, P. Mast cells and histamine concentration in muscle and liver of dystrophic mice. Amer. J. Physiol. 206, 338 (1964).
Bonati, B., C. Lacerenza, G. B. Rancati e L. T. Tenconi: Studio comparativo sul comoratamento della glutamico-ossalacetico transaminasi serica ed epatica in scariate situazioni morbose e nel corso dello shock chirurgico. Minerva med. 47, 267 (1956).
Bond, T. P., M. A. Guest, and M. M. Guest: Blood clotting and fibrinolytic studies in patients with muscular dystrophy. Tex. Rep. Biol. Med. 22, 886 (1964).
Bonetti, E., F. N. Toschi e M. Levi: Le frazioni del fosforo acido-solubile nella distrofia muscolare progressiva. Sperimentale 104, 315 (1954).
Borsook, H., and J. W. Dubnoff: The hydrolysis of phosphocreatine and the origin of urinary creatinine. J. biol. Chem. 168, 493 (1947).
Bourdakos, N., and S. Wolf: Creatine and muscular dystrophy. Arch. Neurol. (Chic.) 6, 439 (1962).
Bourne, G. H., and M. N. Golarz: Histochemical demonstration of acetylphosphate phosphatase in normal and dystrophic human muscle. Arch. Biochem. 85, 109 (1959).
Bourne, G. H., and M. N. Golarz Human muscular dystrophy as an aberration of the connective tissue. Nature (Lond.) 183, 1741 (1959).
Bourne, G. H., and M. N. Golarz Histochemical evidence for a possible primary biochemical lesion in muscular dystrophy. J. Histochem. Cytochem. 11, 286 (1963).
Boyd, J. W.: L-Lactate dehydrogenase isoenzyme in serum and tissues from lambs with acute muscular dystrophy. Biochem. J. 92, 17 p (1964).
Boyer, S. H., D. C. Fainer, and M. A. Naughton: Myoglobin: Inherited structural variation in man. Science 140, 1228 (1963).
Boyer, S. H., D. C. Fainer Genetics and disease of muscle. Amer. J. Med. 35, 622 (1963).
Bozzi, E.: Pediatria 12, 353 (1953).
Bramwell, E.: Muscular dystrophy, sympathetic system and endocrine glands. Lancet 1925, 1103.
Brandt, D. E., and C. R. Leeson: Structural differences of fast and slow fibers in human extraocular muscle. Amer. J. Ophthal. 62, 478 (1966).
Braun, P.: Contribution to the study of postnatal changes in the skeletal muscle in man. Folia morph. (Praha) 15, 11 (1967).
Breemen, V. L. Van: Ultrastructure of human muscle. II. Observations on dystrophic striated muscle fibers. Amer. J. Path. 37, 333 (1960).
Breton, A., B. Gaudier, M. Traisnel et C. Ponte: Étude du taux des transaminases et de l’aldolase sériques au cours des myopathies. Presse méd. 67, 2329 (1959).
Breton, A., B. Gaudier, M. Traisnel et C. Ponte Étude du taux des transaminases et de l’aldolase sériques au cours des myopathies. Pédiatrie 15, 19 (1960).
Brick, I. B.: The clinical significance of aminoaciduria. New Engl. J. Med. 247, 635 (1952).
Brody, I. A., and W. K. Engel: Isozyme histochemistry: The display of selective lactate dehydrogenase isozymes in sections of skeletal muscle. J. Histochem. Cyto-chem. 12, 687 (1964).
Brody, I. A. The significance of lactate dehydrogenase isozymes in abnormal human skeletal muscle. Neurology (Minneap.) 14, 1091 (1964).
Brody, I. A. Effect of denervation on the lactate dehydrogenase isozymes of skeletal muscle. Nature (Lond.) 205, 196 (1965).
Brody, I. A. Clinical biochemistry of the myopathies. In: Current Concepts of Myopathies. Edit. by W. K. Engel. Philadelphia: J. B. Lippingcott 1966, p. 74.
Brooke, M. H., and W. K. Engel: Use of phenazine methosulfate in enzyme histochemistry of human muscle biopsies. Neurology (Minneap.) 16, 986 (1966).
Broser, F.: Das Verhalten der Serumcholinesterase im Verlauf der Myasthenia gravis pseudoparalytica. Ein Beitrag zur Unterscheidung verschiedener Formen des my-asthenischen Syndromes. Nervenarzt 35, 49 (1964).
Brugsch, J., H. Möller u. H. Obstoi: Erfahrungen mit der Glutaminsäure-Therapie bei der progressiven Muskeldystrophie. Z. ges. inn. Med. 7, 441 (1951).
Brugsch, J. u. K. Brockmann-Rohne: Untersuchungen zur klinischen Problematik der progressiven Muskeldystrophie. Leipzig: G. Thieme 1958.
Brugsch, J. u. K. Brockmann-Rohne u. H. Fromm: Enzymveränderungen im Blut bei progressiver Muskeldystrophie. Z. ges. inn. Med. 15, 891 (1960).
Brumlick, J., H. Wachs, W. Hummel, and B. Boshes: Dermatomyositis. A discussion of the recent literature and report of two cases. Quart. Bull. Northw. Univ. med. Sch. 33, 22 (1959).
Bruns, F., u. W. Puls: Die Aktivität der Serumaldolase bei Erkrankungen der Leber. Ein neuer enzymatischer Test. Klin. Wschr. 32, 656 (1954).
Buckley, R. D., D. D. Schottelius, and B. A. Schottelius: Influence of antioxidants on myoglobin concentrations in vitamin E-deficient guinea pig skeletal muscle. Proc. Soc. exp. Biol. (N. Y.) 114, 614 (1963).
Bunting, C. H.: Amer. J. med. Sci. 135, 244 (1908).
Bunyan, J., E. A. Murrell, J. Green, and A. T. Diplock: On the existence and significance of lipid peroxides in vitamin E-deficient animals. Brit. J. Nutr. 21, 475 (1967).
Burger, A., R. Richterich u. H. Aebi: Die Heterogenität der Kreatin-Kinase. Biochem. Z. 339, 305 (1963).
Buscaino, G. A.: Panorama patogenetico-biochimico delle distrofie muscolari e della miotonia. Acta neurol. (Napoli) 14, 1 (1959).
Buscaino, G. A. ed A. Corsi: Studio elettroforetico delle proteine muscolari in soggetti con affezioni neuromuscolari. Acta neurol. (Napoli) 14, 397 (1959).
Buscaino, G. A. eV. Spadetta: Studio sulla sideremia di soggetti con distrofia muscolare progressiva in condizioni basalie dopo terapia rimetabolizzante. Acta neurol. (Napoli) 19, 509 (1964).
Buscaino, G. A. ed O. Sepe: Il comportamento della attivita aldolasica e transaminasica serica nella distrofia muscolare progressiva in condizioni die base e dopo terapia anabolizzante e rimetabolizzante. Acta neurol. (Napoli) 19, 523 (1964).
Buscaino, G. A. Comparison of the serum iron level and the muscular myoglobin content in neuromuscular diseases. Proc. 8th Int. Congr. Neurology, Vienna 1965, Tom. II, p. 199.
Buscaino, G. A. Sideremia e mioglobina muscolare nella distrofia muscolare progressiva ed in altre malattie neuromuscolari. Acta neurol. (Napoli) 21, 26 (1966).
Cahn, R. D., N. O. Kaplan, L. Levine, and E. Zwilling: Nature and development of lactic dehydrogenases. Science 136, 962 (1962).
Calvert, C. C., M. C. Nesheim, and M. L. Scott: Effectiveness of selenium in prevention of nutritional muscular dystrophy in the chick. Proc. Soc. exp. Biol. (N. Y.) 109, 16 (1962).
Calvi, L. A.: Processi ossido-riduttivi e fenomeni di affaticamento nella distrofia muscolare progressiva, ricerche sulla mucoproteinuria. Riv. Pat. nerv. ment. 77, 657 (1956).
Camp, W. A., and W. K. Engel: Myopathies associated with other diseases. In: Current Concepts of Myopathies. Edit. by W. K. Engel. Philadelphia: J. B. Lippingcott 1966, p. 19.
Canal, K, L. Frattola, and A. E. Poloni: Studies on the “pentose phosphate” pathway in denervated skeletal muscle. Med. exp. (Basel) 10, 79 (1964).
Cao, A., A. Macciotta, G. Fiorelli, P. M. Mannucci, and G. Ideo: Chromatographic and electrophoretic pattern of lactate and malate dehydrogenase in normal human adult and foetal muscle and in muscle of patients affected by Duchenne muscular dystrophy. Enzym. biol. clin. 7, 156 (1966).
Carey, M. M., and D. D. Dziewiatkowski: The adenosinetriphosphatase and phosphatase (acid and alkaline) activity of muscle homogenates from rabbits on a vitamin E-deficient diet. J. biol. Chem. 179, 119 (1949).
Carpenter, M. P., A. E. Kitabchi, P. B. McCay, and R. Caputto: The activation by tocopherol and other agents of ascorbic acid synthesis by liver homogenates from vitamin E-deficient rats. J. biol. Chem. 234, 2814 (1959).
Caruso, G., and F. Buchthal: Refractory period of muscle and electromyographic findings in relatives of patients with muscular dystrophy. Brain 88, 29 (1965).
Carver, M. J., S. J. Dutch, and C. L. Wittson: Aminoaciduria in representative neuromuscular disorders. Metabolism 10, 582 (1961).
Cassens, R. G., W. G. Hoekstra, E. C. Faltin, and E. J. Briskey: Zinc content and subcellular distribution in red vs. white porcine skeletal muscle. Amer. J. Physiol. 212, 688 (1967).
Casula, D., P. Cherchi, and A. Spinazzola: Contribution to the blood enzyme picture during muscular work. G. Clin. med. 42, 499 (1961).
Cattaneo, C., e B. Mariani: Ricerche sui poteri enzimatici del sangue nelle miopatie. 44e Congr. Soc. ital. Med. intern. Pozzi, Roma 1938, p. 79.
Cerretelli, P., A. Cantone, M. L. Morandini, and R. Mammano: Effect of fatigue on the efflux of aldolase from isolated muscle. Boll. Soc. ital. Biol. sper. 35, 1935 (1959).
Chadd, M., O. P. Gray, R. A. Saunders, and R. T. Jones: Serum aldolase and phosphocreatine kinase in umbilical cord blood. J. clin. Path. 19, 600 (1966).
Chanutin, A.: The fate of creatine when administered to man. J. biol. Chem. 67, 29 (1926).
Chinoy, N. J.: Histochemical localization of myoglobin in the pigeon breast muscle. J. Anim. Morph. Physiol. 10, 74 (1963).
Chowdhury, S. R., C. M. Pearson, W. W. Fowler Jr., and W. H. Griffith: Serum enzyme studies in muscular dystrophy. III. Serum malic dehydrogenase, 5-nucleotidase and adenosine-triphosphatase. Proc. Soc. exp. Biol. (N. Y.) 109, 227 (1962).
Chung, C. S., N. E. Morton, and H. A. Peters: Discrimination of genetic entities in muscular dystrophy. Amer. hum. Genet. 11, 339 (1959).
Chung, C. S., N. E. Morton, and H. A. Peters Serum enzymes and genetic carriers in muscular dystrophy. Amer. J. hum. Genet. 12, 52 (1960).
Chung, C. S. Serum enzymes and genetics of muscular dystrophy. In: Progressive Muskeldystrophie, Myotome, Myasthenie. Hrsg. von E. Kuhn. Berlin-Heidelberg-New York: Springer 1966, p. 77.
Citoler, P., L. Benitez u. W. Maurer: Untersuchungen der Protein-Syntheserate in roten und weißen Muskelfasern. Exp. Cell Res. 45, 195 (1967).
Clayton, B. E., K. M. Wilson, and C. O. Carter: Aldolase activity in the plasma or serum of normal children and families with muscular dystrophy. Arch. Dis. Childh. 38, 208 (1963).
Clotten, R.: Aminoacidurie bei Myopathien. In: Myopathien. Hrsg. von R. Beckmann. Stuttgart: G. Thieme 1965, S. 139.
Cohen, L., J. Block, J. Djordjevich, and E. Bay: Sex-related difference in serum lactic dehydrogenase (LDH) isozymes. J. Lab. clin. Med. 68, 865 (1966).
Coleman, D. L., and M. E. Ashworth: Incorporation of glycine-1-C14 into nucleic acids and proteins of mice with hereditary muscular dystrophy. Amer. J. Physiol. 197, 839 (1959).
Coleman, D. L., and M. E. Ashworth Influence of diet on transaminase activity in dystrophic mice. Amer. J. Physiol. 199, 927 (1960).
Coleman, R. F., A. W. Nienhuis, W. J. Brown, T. L. Munsat, and C. M. Pearson: New myopathy with mitochondrial enzyme hyperactivity. Histochemical demonstration. J. Amer. med. Ass. 199, 624 (1967).
Coletta, A., M. Berni Canani, F. Schettini, F. Rea e F. Cigala: Aspetti biochimici della distrofia muscolare progressiva. Pediatria (Napoli) 70, 779 (1962).
Colombo, J. P., R. Richterich u. E. Rossi: Serum-Kreatin-Phosphokinase: Bestimmung und diagnostische Bedeutung. Klin. Wschr. 40, 37 (1962).
Cope, F. W., and B. D. Polis: Increased plasma glutamic oxalacetic transaminase activity in monkeys due to non-specific stress effect. J. Aviat. Med. 30, 90 (1959).
Corridori, F.: Research on the electrophoretic picture of the blood proteins and glycoproteins in progressive muscular dystrophy and in dystrophia myotonica. Riv. sper. Freniat. 84, 52 (1960).
Coursini, F., ed E. Cacciari: La glicolisi e l’aldolasi eritrocitarie nella distrofia muscolare. Clin. pediat. (Bologna) 40, 743 (1958).
Craver, W. L., G. Johnson, and J. M. Beal: Alterations in serum glutamic-oxal-acetic transaminase activity following operations. Surg. Forum 8, 77 (1957).
Crowe, G. G.: Acute dilation of stomach as complication of muscular dystrophy. Brit. med. J. 1961, 1371.
Cumings, J. N.: Potassium content of muscle in disease. Brain 62, 153 (1939).
Cumings, J. N. and O. Maas: Blood changes in dystrophia myotonica. Brain 62, 422 (1939).
Cumings, J. N. Creatine and guanidoacetic acid metabolism in muscle disease. Brain 76, 299 (1953).
Cutillo, S., A. Coletta, F. Rea, and M. Berni-Canani: On the behavior of some enzyme activities in the serum of a patient with progressive muscular dystrophy during viral hepatitis. Boll. Soc. ital. Biol. sper. 39, 762 (1963).
Cutillo, S., F. Rea, M. Berni Canani e G. Stoppoloni: Studio delle curve glicemiche dopo somministrazione di adrenalina, glucagone, glucosioinsulina e tolbutamide in bambini con distrofia muscolare progressiva. Pediatria (Napoli) 74, 176 (1966).
D’abbicco, V., ed A. D. Tullio: Variazione della attivita dell’aminoferasi (transaminasi) del siero nei pazienti chirurgici. Acta chir. ital. 14, 539 (1958).
Dam, H.: Relationship of vitamin E-deficiency to tissue peroxides. Ann. N. Y. Acad. Sci. 52, 195 (1949).
Dam, H., I. Prange, and E. Sondergaard: Muscular degeneration (white striation of muscles) in chicks reared on vitamin E-deficient, low fat diets. Acta path. microbiol. scand. 31, 172 (1953).
Danowski, T. S.: Electrolyte and endocrine studies in muscular dystrophy. Amer. J. phys. Med. 34, 281 (1955).
Danowski, T. S., R. Schwartz, G. J. Rhodes, R. D. Yoder, A. J. Puntereri, and F. M. Mateer: Serum protein-bound iodine levels following administration of thyroxin in various diseases. J. clin. Endocr. 15, 1116 (1955).
Danowski, T. S, P. M. Wirth, M. H. Leinberger, L. A. Randall, and J. H. Peters: Muscular dystrophy. III. Serum and blood solutes and other laboratory indices. Amer. J. Dis. Child. 91, 346 (1956).
Danowski, T. S, R. M. Bastiani, F. D. McWilliams, F. M. Mateer, and L. Greenman: Muscular dystrophy. IV. Endocrine studies. Amer. J. Dis. Child. 91, 356 (1956).
Danowski, T. S, H. K. Gillespie, T. J. Egan, F. M. Mateer, and M. H. Leinberger: Muscular dystrophy. V. Blood sugar and serum electrolytes following insulin and dextrose, alone or in combination. Amer. J. Dis. Child. 91, 429 (1956).
— The clinical implications of basic research in muscular dystrophy. Chapter Repr. Meeting, Musc. Dystr. Ass. America, Atlantic City, June 1958.
Danowski, T. S, J. Van Diermen, A. C. Heineman, and F. M. Mateer: Muscular dystrophy. X. Endocrine and electrolyte effects of methyltestosterone-KCl therapy. Amer. J. Dis. Child. 97, 555 (1959).
Dawson, D. M., T. L. Goodfriend, and N. O. Kaplan: Lactic dehydrogenases. Functions of the two types and rates of synthesis of the two major forms which can be correlated with metabolic differentiation. Science 143, 929 (1964).
Dawson, D. M. and F. C. A. Romanul: Enzymes in muscle. II. Histochemical and quantitative studies. Arch. Neurol. (Chic.) 11, 369 (1964).
Dawson, D. M. and N. O. Kaplan: Factors influencing the concentration of enzymes in various muscles. J. biol. Chem. 240, 3215 (1965).
Dawson, D. M. Leakage of enzymes from denervated and dystrophic chicken muscle. Arch. Neurol. (Chic.) 14, 321 (1966).
Dawson, D. M. Efflux of enzymes from chicken muscle. Biochim. biophys. Acta (Amst.) 113, 144 (1966).
Dawson, D. M. and I. H. Fine: Creatine kinase in human tissues. Arch. Neurol. (Chic.) 16, 175 (1967).
Debré, R., J. Marie et D. Nachmansohn: Étude chimique du muscle prélevé par biopsie dans la myopathie. C. R. Acad. Sci. (Paris) 202, 520 (1936).
Delbrück, A.: Untersuchungen über Enzyme des Energie-Stoffwechsels im Bindegewebe. Klin. Wschr. 40, 677 (1962).
Delbrück, A. Enzymverteilungsmuster gefäßloser Gewebe. Klin. Wschr. 41, 488 (1963).
Delbrück, A. Zur Enzymologie der Bindegewebe. Enzym. biol. clin. 4, 84 (1964).
Della Porta, P., e B. Soldati: Valutazione della funzionalita miocardica mediante il test d’ipossia in un gruppo di soggetti miopatici. Folia cardiol. (Milano) 22, 101 (1963).
Demos, J., et J. Coiffier: Troubles circulatoires au cours de la myopathie. Études artériographiques. Rev. franç. Étud. clin. biol. 2, 489 (1957).
Demos, J., C. Bohuon u. P. Maroteaux: Une nouvelle technique de mesure de temps de circulation générale de bras. à bras Rev. franç. Étud. clin. biol. 5, 707 (1960).
Demos, J. Un nouveau problème posé par la myopathie humaine: les troubles des temps de circulation et leur liaison avec l’activité enzymatique sérique. Bull. Soc. méd. Hôp. (Paris) 77, 636 (1961).
Demos, J., J. C. Dreyfus, F. Schapira et G. Schapira: Anomalies biologiques chez les transmetteurs apparemment sains de la myopathie. Rev. canad. Biol. 21, 587 (1962).
Demos, J. et G. Schapira: Enzymes sériques et temps de circulation au cours des myopathies. Ann. Méd. phys. 5, 273 (1963).
Denny-Brown, D.: The histological features of striped muscle in relation to its functional activity. Proc. roy. Soc. Med. 104, 371 (1929).
Desai, I. D., C. C. Calvert, M. L. Scott, and A. L. Tappel: Peroxidation and lysosomes in nutritional muscular dystrophy of chicks. Proc. Soc. exp. Biol. (N. Y.) 115, 462 (1964).
Desai, I. D., C. C. Calvert, M. L. Scott, and A. L. Tappel A time-sequence study of the relationship of peroxidation, lysosomal enzymes, and nutritional muscular dystrophy. Arch. Biochem. 108, 60 (1964).
Diehl, J. F.: Amino aciduria of E-avitaminosis. Exceptional role of glycine. Proc. Soc. exp. Biol. (N. Y.) 100, 657 (1959).
Diessner, G. R., F. M. Howard Jr., R. K. Winkelmann, E. H. Lambert, and D. W. Mulder: Laboratory tests in polymyositis. Arch. intern. Med. 117, 757 (1966).
Dinning, J. S.: Some effects of vitamin E on amino acid metabolism. Fed. Proc. 12, 412 (1953).
Dinning, J. S. The role of vitamin E in regulating the turnover rate of nucleic acids. J. biol. Chem. 212, 735 (1955).
Dinning, J. S., J. T. Sime, and P. L. Day: The influence of vitamin E-deficiency on the metabolism of sodium formate-C14 and glycine-1-C14 by the rabbit. J. biol. Chem. 217, 205 (1955).
Dinning, J. S., J. T. Sime, and P. L. Day An increased incorporation of P32 into nucleic acids by vitamin E-deficient rabbits. J. biol. Chem. 222, 215 (1956).
Dinning, J. S., K. W. Cosgrove, C. D. Fitch, and P. L. Day: Influence of vitamin E-deficiency in rabbits on urinary excretion of free amino acids. Proc. Soc. exp. Biol. (N. Y.) 91, 632 (1956).
Dinning, J. S. and P. L. Day: Vitamin E-deficiency in the monkey. III. The metabolism of sodium formate-C14. J. biol. Chem. 233, 240 (1958).
Dinning, J. S. and C. D. Fitch: Creatine metabolism in vitamin E-deficiency. Proc. Soc. exp. Biol. (N. Y.) 97, 109 (1958).
Dobashi, S.: Studies on the clinical significance of malic dehydrogenase activity in infancy and childhood. III. On the serum malic dehydrogenase activity in diseases of muscles and nervous system. Acta paediat. jap. 8, 34 (1966).
Dobson, H. L., and M. Kasahara: NADH2 — cytochrome c reductase and cytochrome c oxidase in experimental muscle disorders. Tex. Rep. Biol. Med. 22, 890 (1964).
Domonkos, J.: The metabolism of the tonic and tetanic muscles. I. Glycolytic metabolism. Arch. Biochem. 95, 138 (1961).
Domonkos, J. and L. Latzkovits: The metabolism of the tonic and tetanic muscles. II. Oxidative metabolism. Arch. Biochem. 95, 144 (1961).
Domonkos, J. The metabolism of the tonic and tetanic muscles. III. Pyruvate metabolism of the tonic and tetanic muscle. Arch. Biochem. 95, 147 (1961).
Donaldson, J. S., M. J. Wratney, A. Pascassio, F. A. Weigand, and T. S. Danowski: Muscular dystrophy. III. Serum and blood solutes and other laboratory indices. Amer. J. Dis. Child. 91, 346 (1956).
Dowben, R. M., and K. R. Holley: Erythrocyte electrolytes in muscle disease. J. Lab. clin. Med. 54, 867 (1959).
Dowben, R. M. and M. A. Perlstein: Muscular dystrophy treated with norethandrolone. Arch. intern. Med. 107, 245 (1961).
Drachman, D. B., S. R. Murphy, M. P. Nigam, and J. R. Hills: “Myopathic” changes in chronically denervated muscle. Arch. Neurol. (Chic.) 20, 14 (1967).
Drew, A. L., and B. T. Selving: Observations on pentosuria in neuromuscular disorders. Neurology (Minneap.) 3, 563 (1953).
Dreyfus, J. C., et G. Schapira: Les syndromes biochimiques musculaires. Dans: Le Muscle. Étude de Biologie et de Pathologie. Moulins: Crepin-Leblond 1950, p. 357.
— Iron metabolism in muscular diseases. Proc. 1st Med. Conf. Musc. Dystr. Ass. America, New York 1951, p. 16.
Dreyfus, J. C. et G. Schapira: Glycogénolyse et phosphoglucomutase du muscle humain normal et myopathique. C. R. Soc. Biol. (Paris) 147, 1145 (1953).
Dreyfus, J. C., M. Joly, G. Schapira et L. Raeber: Modifications précoces de la biréfringence d’écoulement de solutions de myosine après section nerveuse. C. R. Acad. Sci. (Paris) 236, 2351 (1953).
Dreyfus, J. C., G. Schapira, and F. Schapira: Biochemical study of muscle in progressive muscular dystrophy. J. clin. Invest. 33, 794 (1954).
Dreyfus, J. C., G. Schapira, and F. Schapira L’activité transaminasique du sérum au cours des myopathies. C. R. Soc. Biol. (Paris) 149, 1934 (1955).
Dreyfus, J. C., G. Schapira, and F. Schapira, F. Schapira et J. Demos: Activités enzymatiques du muscle humain. Recherches sur la biochimie comparée de l’homme normal et myopathique et du rat. Clin. chim. Acta 1, 434 (1956).
Dreyfus, J. C., G. Schapira, and F. Schapira Serum enzymes in physiopathology of muscles. Ann. N. Y. Acad. Sci. 75, 235 (1958).
Dreyfus, J. C., G. Schapira, and F. Schapira et J. Demos: Études des différences artérioveineuses au cours des myopathies. 1. Oxygène, glucose et acide lactique. 2. Aldolase plasmatique. Clin. chim. Acta 3, 571 (1958).
Dreyfus, J. C., G. Schapira, and F. Schapira Enzymes musculaires et sériques en pathologie musculaire. Dans: Régulations enzymatiques en clinique. Édit par A. Gijon et H. Ludwig. Basel: B. Schwabe 1960.
Dreyfus, J. C., G. Schapira, and F. Schapira and J. Demos: Study of serum creatine kinase in myopathic patients and their families. Rev. franç. Étud. clin. biol. 5, 384 (1960).
Dreyfus, J. C., G. Schapira, and F. Schapira, J. Demos, F. Schapira et G. Schapira: La lacticodèshydrogénase musculaire chez le myopathe: persistance apparente du type fétal. C. R. Acad. Sci. (Paris) 254, 4384 (1962).
Dreyfus, J. C., G. Schapira, and F. Schapira u. G. Schapira: Biochemie der progressiven Muskeldystrophie. Klin. Wschr. 40, 373 (1962).
Dreyfus, J. C., G. Schapira, and F. Schapira Biochemistry of hereditary myopathies. Springfield, Ill.: Ch. Thomas 1962.
Dreyfus, J. C., G. Schapira, and F. Schapira Problems in the biochemistry of progressive muscular dystrophy. In: Research in Muscular Dystrophy. London: Pitman 1962, p. 127.
Dreyfus, J. C., G. Schapira, and F. Schapira, F. Schapira, J. Demos, R. Rosa, and G. Schapira: The value of serum enzyme determinations in the identification of dystrophic carriers. Ann. N. Y. Acad. Sci. 138, 304 (1966).
Dreyfus, J. C., G. Schapira, and F. Schapira et G. Schapira: Biochimie et enzymologie des dystrophies musculaires (Myopathies). In: Progressive Muskeldystrophie, Myotonie, Myasthenie. Hrsg. von E. Kuhn. Berlin-Heidelberg-New York: Springer 1966, p. 42.
Dryer, R. L., A. R. Tammes, J. I. Routh, and W. D. Paul: Blood lipids in progressive muscular dystrophy. Proc. Iowa Acad. Sci. 63, 398 (1956).
Dubach, U. C.: Diagnostische Bedeutung der Serum-Glutaminsäure-Oxalessigsäure-transaminase. Helv. med. Acta 24, 357 (1957).
Dubach, U. C.: Die Glutaminsäure-Oxalessigsäure-Transaminase in ihrer diagnostischen Bedeutung. Z. klin. Med. 154, 593 (1957).
Dubowitz, V., and A. G. E. Pearse: A comparative study of oxidative enzyme and phosphorylase activity in skeletal muscle. Histochemie 2, 105 (1960).
Dubowitz, V. Reciprocal relationship of phosphorylase and oxidative enzymes in skeletal muscle. Nature (Lond.) 185, 701 (1960).
Dubowitz, V. Enzymic activity of normal and dystrophic human muscle: a histochemical study. J. Path. Bact. 81, 365 (1961).
Dubowitz, V. Myopathic changes in a muscular dystrophy carrier. J. Neurol. Neurosurg. Psychiat. 26, 322 (1963).
Dubowitz, V. and A. G. E. Pearse: Histochemical aspects of muscle disease. In: Disorders of Voluntary Muscle. Edit. by J. N. Walton. London: J. A. Churchill 1964, p. 194.
Dubowitz, V. Enzyme histochemistry of skeletal muscle. I. Developing animal muscle. II. Developing human muscle. J. Neurol. Neurosurg. Psychiat. 28, 516 (1965).
Dubowitz, V. Enzyme histochemistry of skeletal muscle. III. Neurogenic muscular atrophies. J. Neurol. Neurosurg. Psychiat. 29, 23 (1966).
Dubowitz, V. and D. L. Newman: Change in enzyme pattern after cross-innervation of fast and slow skeletal muscle. Nature (Lond.) 214, 840 (1967).
Dubowitz, V. Further studies on fibre types in skeletal muscle. In: Research in Muscular Dystrophy. London: Pitman 1968, p. 100.
Dudley, M., and W. C. Gibson: Photomicrographic study on the capillary nail beds of muscular dystrophy patients. Canad. med. Ass. J. 90, 1226 (1964).
Duve, C.De: Lysosomes, a new group of cytoplasmic particles. In: Subcellular particles. Edit. by T. Hayashi. New York: Ronald Press 1959, p. 128.
Ebashi, S., Y. Toyokura, H. Momoi, and H. Sugita: High creatine phosphokinase activity of sera of progressive muscular dystrophy. J. Biochem. (Tokyo) 46, 103 (1959).
Eckert, H., u. R. Kirst: Das Herz bei der Dystrophia musculorum progressiva (Erb). Zbl. allg. Path. path. Anat. 109, 264 (1966).
Ekbom, K., R. Hed, C. G. Herdenstam et al.: The serum creatine phosphokinase activity and the Achilles reflex in hyperthyroidism and hypothyroidism. Acta med. scand. 179, 433 (1966).
El-Khatib, S., u. A. Chenau, M. P. Carpenter, R. E. Trucco, and R. Caputto: Possible presence of lipid peroxides in tissues of tocopherol-deficient animals. Nature (Lond.) 201, 188 (1964).
Elkington, J. S. C., and M. W. Goldblatt: Effect of adrenaline in certain muscular disorders. Lancet 1933, 693.
Emery, A. E. H.: Clinical manifestations in two carriers of Duchenne muscular dystrophy. Lancet 1963 I, 1126.
Emery, A. E.: Electrophoretic pattern of lactic dehydrogenase in carriers and patients with Duchenne muscular dystrophy. Nature (Lond.) 201, 1044 (1964).
Emery, A. E.:, D. H. Sherbourne, and A. Pusch: Electrophoretic pattern of muscle lactic dehydrogenase in various diseases. Arch. Neurol. (Chic.) 12, 251 (1965).
Emery, A. E.: Muscle histology in carriers of Duchenne muscular dystrophy. J. med. Genet. 2, 1 (1965).
Emery, A. E. H.: Carrier detection in sex-linked muscular dystrophy. J. Génét. hum. 14, 318 (1965).
Emery, A. E., and F. M. Pascasio: The effects of pregnancy on the concentration of creatine kinase in serum, skeletal muscle, and myometrium. Amer. J. Obstet. Gynec. 91, 18 (1965).
Emery, A. E. H., R. D. Teasdall, and E. N. Coomes: Electromyographic studies in carriers of Duchenne muscular dystrophy. Bull. Johns Hopk. Hosp. 118, 439 (1966).
Engel, W. K.: The essentiality of histo-and cytochemical studies of skeletal muscle in the investigation of neuromuscular disease. Neurology (Minneap.) 12, 778 (1962).
Engel, W. K. and G. G. Cunningham: Rapid examination of muscle tissue. An improved trichrome method for fresh-frozen biopsy sections. Neurology (Minneap.) 13, 919 (1963).
Engel, W. K. Histochemistry of neuromuscular disease. Significance of muscle fiber types. Proc. 8th Congr. Neurology, Vienna 1965, Tom. II, p. 67.
Engel, W. K. and L. A. H. Hogenhuis: Genetically determined myopathies. In: Current Concepts of Myopathy. Edit. by W. K. Engel. Philadelphia: J. B. Lippingcott 1966.
Engel, W. K. Focal myopathic changes produced by electromyographic and hypodermic needles, “needle myopathy”. Arch. Neurol. (Chic.) 16, 509 (1967).
Engelhardt-Gölkel, A., K. Lobel, W. Seitz u. I. Woller: Über das Verhalten und die Herkunft glykolytischer Serumenzyme beim Menschen und ihre diagnostische Bedeutung. Klin. Wschr. 36, 462 (1958).
Eppenberger, M., C. W. Nixon, J. R. Baker, and F. Homburger: Serum phosphocreatine kinase in hereditary muscular dystrophy and cardiac necrosis of Syrian golden hamsters. Proc. Soc. exp. Biol. (N. Y.) 117, 465 (1964).
Erbslöh, F., u. P. Klärner: Vergleichende klinische, bioptische und biochemische Untersuchungen bei chronischen Myopathien. Klin. Wschr. 31, 1059 (1953).
Erbslöh, F. Histo-und biochemische Befunde bei dystrophischen Myopathien. Dtsch. Z. Nervenheilk. 173, 503 (1955).
Ernst, K., u. P. Wiechert: Biochemische Untersuchungen bei progressiver Muskeldystrophie. Nervenarzt 35, 354 (1964).
Eshchar, J., and H. J. Zimmerman: Creatine phosphokinase in disease. Amer. J. med. Sci. 253, 272 (1967).
Evans, J. H., and R. W. R. Baker: Serum aldolase and the diagnosis of myopathy. Brain 80, 557 (1957).
Evans, T. C., Jr., and B. A. Schottelius: Phase portraits of dystrophic and non-dystrophic mouse muscle-fiber action potentials. Amer. J. Physiol. 208, 724 (1965).
Evans, T. C., Jr., and B. A. Schottelius Phase portraits of normal mouse muscle-fiber action potentials in high calcium. Amer. J. Physiol. 208, 732 (1965).
Fahimi, H. D., and C. R. Amarasingham: Cytochemical localization of lactic dehydrogenase in white skeletal muscle. J. Cell Biol. 22, 29 (1964).
Fahimi, H. D. and P. Roy: Cytochemical localization of lactate dehydrogenase in muscular dystrophy of the mouse. Science 152, 1761 (1966).
Farrell, P. M., E. L. Eyerman, and L. L. Tureen: Comparison of plasma creatine phosphokinase changes in nutritional and genetic muscular dystrophy in the chicken. Ann. N. Y. Acad. Sci. 138, 102 (1966).
Farriaux, J. P., A. Hoste, M. P. Guinamakd, R. Havez, G. Fontaine et L. Christiaens: Étude de la lactico-dèshydrogénase et de ses iso-enzymes dans la dystrophie musculaire progressive de l’enfant. Pédriatrie 21, 443 (1966).
Fassio, E.: Les manifestations digestives et biliaires des myopathies. Presse méd. 59, 191 (1951).
Feissli, S., G. Forster, G. Laudahn, E. Schmidt u. F. W. Schmidt: Normal-Werte und Alterung von Hauptketten-Enzymen im Serum. Klin. Wschr. 44, 390 (1966).
Felsch, G., O. Hoffmeyer u. G. Richter: Herzbeteiligung bei Dystrophia musculorum progressiva Erb. Z. ges. inn. Med. 21, 73 (1966).
Fenichel, G. M., and W. K. Engel: Histochemistry of muscle in infantile spinal muscular atrophy. Neurology (Minneap.) 13, 1059 (1963).
Fenichel, G. M. A histochemical study of developing human skeletal muscle. Neurology (Minneap.) 16, 741 (1966).
Fenn, W. O., and M. Goettsch: Electrolytes in nutritional muscular dystrophy in rabbits. J. biol. Chem. 120, 41 (1937).
Fergus, E. B., W. R. Nichols, L. M. Horne, and T. S. Danowski: Muscular Dystrophy. VI. Diminished blood sugar and serum electrolyte responses to epinephrine. Amer. J. Dis. Child. 91, 436 (1956).
Ferraro, A.: Su la natura disendocrina delle miopatie. Cervello 2, 382 (1923).
Feuer, C., and A. Frigyes: Change of adenosinetriphosphatase activity in the case of muscular dystrophy due to vitamin E-deficiency. Acta physiol. Acad. Sci. hung. 3, 1 (1953).
Fildes, R. A., and H. Harris: Genetically determined variation of adenylate kinase in man. Nature (Lond.) 209, 261 (1966).
Filippi, G., and A. Macciotta: Xg blood-groups in muscular dystrophy. Lancet 1967 I, 565.
Fink, K.: Biochemical studies of skeletal muscle in mice with hereditary muscular dystrophy. Fed. Proc. 20, 303 (1961).
Fitch, C. D., J. D. Oates, and J. S. Dinning: The metabolism of creatine-1-C14 by mice with hereditary muscular dystrophy. J. clin. Invest. 40, 850 (1961).
Fitch, C. D. and D. W. Sinton: A study of creatine metabolism in diseases causing muscle wasting. J. clin. Invest. 43, 444 (1964).
Fitzpatrick, K., D. C. Park, R. J. Pennington, J. Robinson and M. Worsfold: Further studies on muscle cathepsins. In: Research in Muscular Dystrophy. London: Pitman 1968, p. 374.
Flores, E. F., M. Johnson, and P. Valledor: Rev. cuba. Pediat. 21, 222 (1949).
Forster, G., and E. Jenny: The phosphofructaldolase test in liver diagnosis. Helv. med. Acta 26, 673 (1959).
Forster, G. and J. Escher: Creatine phosphokinase in the diagnosis of myocardial infarction and myopathies. Helv. med. Acta 28, 513 (1961).
Forster, G. Liver-and muscle-specific enzyme diagnosis. Schweiz. med. Wschr. 92, 1422 (1962).
Forster, G. Die diagnostische Bedeutung der Serum-Kreatinkinase. Praxis 52, 1177 (1963).
Forster, G. Zur Enzymdiagnostik von Herzinfarkt und Myopathien. Schweiz. med. Wschr. 97, 329 (1967).
Fowler, W. M., S. R. Chowdhury, C. M. Pearson, G. Gardner, and R. Bratton: Changes in serum enzyme levels after exercise in trained and untrained subjects. J. appl. Physiol. 17, 943 (1962).
Friedman, I., and H. A. Mattill: The oxygen consumption of skeletal muscle from animals deprived of vitamin E. Amer. J. Physiol. 131, 595 (1941).
Friedman, M. M., and B. Lapan: Serum aldolase in the neonatal period, including a colorimetric determination of aldolase by standardization with dihydroxyacetone. J. Lab. clin. Med. 51, 745 (1958).
Friedrichs, H. F., u. E. J. Kirnberger: Die progressive Muskeldystrophie als Erscheinungsbild eines genbedingten fermentativen Wirknetzes. Ärztl. Forsch. 13, 454 (1959).
Fritz, I. B., D. G. Davis, R. H. Holtrop, and H. Dundee: Fatty acid oxidation by skeletal muscle during rest and activity. Amer. J. Physiol. 194, 379 (1958).
Fritz, P. J., and K. B. Jacobson: Lactic dehydrogenases; subfractionation of isozymes. Science 140, 64 (1963).
Gabrilove, J. L., A. Saito, L. L. Shane, and L. J. Soffer: The urinary excretion of adrenal corticoid metabolites in myotonic dystrophy. J. Mt Sinai Hosp. 30, 294 (1963).
Gailani, S., T. S. Danowski, and D. S. Fischer: Muscular dystrophy catheterization studies indicating latent congestive heart failure. Circulation 17, 583 (1958).
Gambetti, P., D. Karcher et A. Lowenthal: Protéinogrammes et enzymogrammes de biopsies musculaires humaines. Rev. franç. Étud. clin. biol. 10, 973 (1965).
Gandullia, E., e G. Gaiero: L’aminoaciduria nella distrofia muscolare progressiva. Minerva pediat. 15, 731 (1963).
Ganz, H.: Enzymmuster von Kehlkopfmuskeln des Menschen und ihre Bedeutung für deren Funktion an der Glottis. Arch. Ohr.-, Nas.-u. Kehlk.-Heilk. 184, 10 (1964).
Garcia-Buñuel, L., V. M. Garcia-Buñuel, L. Green, and D. K. Subin: Lactate dehydrogenase forms in denervation and disuse atrophy of red and white muscle. Neurology (Minneap.) 16, 491 (1966).
Garcia-Buñuel, L., V. M. Garcia-Buñuel, L. Green, and D. K. Subin Connective tissue and the pentose phosphate pathway in normal and denervated muscle. Nature (Lond.) 213, 913 (1967).
Gardner-Medwin, D., P. Hudgson, and J. N. Walton: Atypical progressive muscular atrophy. Lancet 1967 I, 113.
Gautier, E., R. Gautier et R. Richterich: Valeur diagnostique d’anomalies d’activités enzymatiques du sérum en pédiatrie. I. Valeurs normales et influence des corticostéroides. Helv. paediat. Acta 17, 415 (1962).
Gentili, C., J. Galvani e L. Spettoli: Valore dell’aldolasemia quale criterio diagnostico e prognostico nelle miopatie. Recenti Progr. Med. 27, 93 (1959).
Gentili, C. Significato dell’aumento dell’aldolasi nel siero dei distrofici muscolari. Clin. pediat. (Bologna) 41, 736 (1959).
George, J. C., and R. M. Naik: Relative distribution and chemical nature of the fuel store of the two types of fibers in the pectoralis major of the pigeon. Nature (Lond.) 181, 709 (1958).
George, J. C. and K. S. Scaria: Histochemical demonstration of lipase activity in the pectoralis major muscle of the pigeon. Nature (Lond.) 181, 783 (1958).
George, J. C., A. K. Susheela, and N. V. Vallyathan: Cytoplasmic (non-mitochondrial) lactic and succinic dehydrogenases in the red and white muscle fibres. J. Anim. Morph. Physiol. 10, 24 (1963).
George, J. C. Muscle lipase. J. Anim. Morph. Physiol. 11, 233 (1964).
Gerber, G. B., G. Gerber, T. R. Koszalka, and V. M. Emmel: Creatine metabolism in vitamin E-deficiency in the rat. Amer. J. Physiol. 202, 453 (1962).
Gerber, G. B., W. G. Aldrige, T. R. Koszalka, and G. Gerber: Biochemical and autoradiographic studies on DNA metabolism in vitamin E-deficient hamster. J. Nutr. 78, 307 (1962).
Gerber, G. B., T. R. Koszalka, G. Gerber, and L. L. Miller: Creatine synthesis in perfused liver of vitamin E-deficient rats. Proc. Soc. exp. Biol. (N. Y.) 116, 884 (1964).
Gerlach, U.: Pathologischer Übertritt von Sorbitdehydrogenase ins Blut bei Lebererkrankungen. Klin. Wschr. 35, 1144 (1957).
Gerlach, U. Ergebnisse von Enzymaktivitätsbestimmungen im Serum bei inneren Krankheiten. Dtsch. Arch. klin. Med. 207, 510 (1961).
Gerlach, U.: Stoffwechsel der Skelettmuskulatur. Wien. klin. Wschr. 79, 229 (1967).
Gerok, W., u. J. Gayer: Die tubuläre Rückresorption der L-Aminosäuren in der Niere des Hundes. Transportmaxima und competitive Hemmung. Klin. Wschr. 39, 540 (1961).
Gilbert, R. K., and W. A. Hawk: The incidence of necrosis of muscle fibers in Duchenne type muscular dystrophy. Amer. J. Path. 43, 107 (1963).
Gilroy, J., J. L. Cahalan, R. Berman, and M. Newman: Cardiac and pulmonary complications in Duchenne’s progressive muscular dystrophy. Circulation 27, 484 (1963).
Girkin, G., C. D. Fitch, and J. S. Dinning: Nucleic acid metabolism in mice with hereditary muscular dystrophy. Arch. Biochem. 98, 224 (1962).
Giusti, G., A. Ascione u. L. Cacciatore: Vergleichende Untersuchung einiger TPN-abhängiger Dehydrogenasen und anderer Serum-Enzyme bei Patienten mit progressiver Muskeldystrophie. Klin. Wschr. 45, 292 (1967).
Gloor, U., and O. Wiss: Fat-soluble vitamins. Ann. Rev. Biochem. 33, 313 (1964).
Goettsch, M., and E. F. Brown: Muscle creatine in nutritional muscular dystrophy of the rabbit. J. biol. Chem. 97, 549 (1932).
Goettsch, M., J. Lonstein, and J. Hutchinson: Muscle phosphorus in nutritional muscular dystrophy in rabbits. J. biol. Chem. 128, 9 (1939).
Golarz, M. N.: Histochemical studies of the muscles of dystrophic mice. Anat. Rec. 136, 198 (1960).
Golarz, M. N., G. H. Bourne, and H. D. Richardson: Histochemical studies on human muscular dystrophy. J. Histochem. Cytochem. 9, 132 (1961).
Gollnick, P. D., P. J. Struck, and T. P. Bogyo: Lactic dehydrogenase activities of rat heart and skeletal muscle after exercise and training. J. appl. Physiol. 22, 623 (1967).
Gorbacheva, F. E., i I. M. Sechenon: Aktivnost’ al’dolazy primiopatii u detei. (Russ.) Zh. Nevropat. Psikhiat. 63, 958 (1963).
Gordon, P., and R. M. Dowben: Catecholamine distribution in mice afflicted with muscular dystrophy. Amer. J. Physiol. 210, 728 (1966).
Gortner, R. A., and A. F. Milano: Effects of tocopherol depletion on muscle nuclei acid and creatine levels in the frog. Amer. J. Physiol. 204, 168 (1963).
Gotham, J. E., J. T. McHenry, and M. K. Newman: Serum enzymes in 250 cases of myopathy. Amer. J. phys. Med. 41, 234 (1962).
Goto, I., H. A. Peters, and H. H. Reese: Pyruvic and lactic acid metabolism in muscular dystrophy, neuropathies and other neuromuscular disorders. Amer. J. med. Sci. 253, 431 (1967).
Goto, I., H. A. Peters, and H. H. Reese Creatine phosphokinase in neuromuscular disease. Patients and families. Arch. Neurol. (Chic.) 16, 529 (1967).
Gould, A., and D. L. Coleman: Accumulation of acetoacetate in muscle homogenates from dystrophic mice. Biochim. biophys. Acta (Amst.) 47, 422 (1961).
Gould, A., and D. L. Coleman Acetoacetate metabolism in muscle homogenates from normal and dystrophic mice. Arch. Biochem. 96, 408 (1962).
Graig, F. A., and J. C. Smith: Serum creatine phosphokinase activity in altered thyroid states. J. clin. Endocr. 25, 723 (1965).
Griffiths, P. D.: Serum ATP: creatine phosphotransferase in skeletomuscular disorders with special reference to Duchenne muscular dystrophy. Guy’s Hosp. Rep. 114, 401 (1965).
Griffiths, P. D. Serum levels of ATP: creatine phosphotransferase (creatine kinase). The normal range and effect of muscular activity. Clin. chim. Acta 13, 413 (1966).
Grinio, L. P., i N. I. Pirogov: Issledovanie fermentov syvorotki krovi u detei s progressivnoi myshechnoi distrofiei. (Russ.) Zh. Nevropat. Psikhiat. 63, 691 (1963).
Gros, H., u. E. J. Kirnberger: Stoffwechseluntersuchungen bei progressiver Muskeldystrophie. Klin. Wschr. 30, 780 (1952).
Gros, H., u. E. J. Kirnberger Störungen der fermentativen Oxydation bei Muskelerkrankungen. Klin. Wschr. 32, 645 (1954).
Grundmann, E., u. R. Beckmann: Zur pathologischen Anatomie der Dystrophia musculorum progressiva Erb. Beitr. path. Anat. 127, 335 (1963).
Gsell, O.: Fermente in der klinischen Diagnostik. Münch. med. Wschr. 100, 1161 (1958).
Guarnaschelli-Raggio, A.: La proteinemia nella distrofia muscolare progressiva primitiva. Arch. Stud. Fisiopat. Ricambio 6, 391 (1938).
Guth, L., and P. K. Watson: The influence of innervation on the soluble proteins of slow and fast muscles of the rat. Exp. Neurol. 17, 107 (1967).
Hajek, I., E. Gutmann, and I. Strovy: Proteolytic activity in denervated and reinnervated muscle. Physiol. bohemoslov. 13, 32 (1964).
Haldane, J. B. S.: Mutation in the sex-linked recessive type of muscular dystrophy. A possible sex difference. Ann. hum. Genet. 20, 344 (1955).
Hall, C. E., O. Hall, and A. H. Nevis: Prolongation of survival by parabiosis in strain 129 dystrophic mice. Amer. J. Physiol. 196, 110 (1959).
Hallen, O.: Osseous dystrophy in progressive muscular dystrophy. Proc. 8th Int. Congr. Neurology, Vienna 1965, Tom. II, p. 303.
Halonen, P. I., and A. Konttinen: Effect of physical exercise on some enzymes in the serum. Nature (Lond.) 193, 942 (1962).
Hantschmann, N., D. Matzelt, H. G. Mertens u. H. Nowakowski: Zur Behandlung von Muskelkrankheiten mit anabolen Steroiden. I. Stoffwechseluntersuchungen. Dtsch. med. Wschr. 87, 2619 (1962).
Harman, P. J., J. P. Tassoni, R. L. Curtis, and M. B. Hollinshead: Muscular dystrophy in the mouse. In: Muscular Dystrophy in Man and Animals. Edit. by G. H. Bourne and N. Golarz. New York: Hafner 1963, p. 407.
Haurowitz, F., and R. L. Hardin: In: The Proteins. Edit. by H. Neurath and K. Bailey. New York: Academic Press 1954, p. 323.
Hausmanowa-Petrusewicz, I., J. Prot, I. Niebroj-Dobosz, B. Emeryk, B. Wasowicz, C. Slucka, L. Hetnarska, B. Bandarzweska, and Z. Pucek: Investigation of healthy relatives of patients with Duchenne type dystrophy. Proc. 8th Int. Congr. Neurology, Vienna 1965, Tom. II, p. 635.
Hausmanowa-Petrusewicz, I. Abgrenzung der progressiven Muskeldystrophie von den entzündlichen Muskelerkrankungen. In: Progressive Muskeldystrophie, Myotonie, Myasthenie. Hrsg. von E. Kuhn. Berlin-Heidelberg-New York: Springer 1966, S. 115.
Hazzard, W. R., and S. L. Leonard: Phosphoglucomutase activity in hereditary muscular dystrophy in mice. Proc. Soc. exp. Biol. (N. Y.) 102, 720 (1959).
Hazzard, W. R., and S. L. Leonard Phosphoglucomutase activity in skeletal muscles of vitamin E-deficient chicks. Proc. Soc. exp. Biol. (N. Y.) 106, 839 (1961).
Heinrich, M. R., and H. A. Mattill: The creatine content of the liver in the muscular dystrophy of vitamin E-deficiency. J. biol. Chem. 178, 911 (1949).
Henneman, E., and C. B. Olson: Relations between structure and function in the design of skeletal muscles. J. Neurophysiol. 28, 581 (1965).
Herrmann, H., u. R. Konigsberg, and G. Robinson: Observations on culture in vitro of normal and dystrophic muscle tissue. Proc. Soc. exp. Biol. (N. Y.) 105, 217 (1960).
Herschberg, A. D., R. Coirault et J. Giboudeau: Étude hormonale de la myopathie progressive de Duchenne. I. Les androgènes et les corticoides. Ann. Endocr. (Paris) 25, 529 (1964).
Herschberg, A. D. Rev. franç. Endocr. clin. 5, 354 (1964).
Herschberg, A. D. u. R. Coirault: Innere Sekretion und Kohlenhydratstoffwechsel bei der Dystrophia musculorum progressiva Duchenne-Erb. In: Myopathien. Hrsg. von R. Beckmann. Stuttgart: G. Thieme 1965, S. 127.
Hess, B.: Enzyme im Blutplasma. Stuttgart: G. Thieme 1962.
Hess, J. W., and R. P. Macdonald: Serum creatine phosphokinase activity. A new diagnostic aid in myocardial and skeletal muscle disease. J. Mich. med. Soc. 62, 1095 (1963).
Hess, J. W., R. J. Frederick, R. N. Jones, J. Neely, and R. Gross: Serum creatine phosphokinase (CPK) activity in disorders of heart and skeletal muscle. Ann. intern. Med. 61, 1015 (1964).
Hess, J. W. Phosphorylase activity and glycogen, glucose-6-phosphate and lactic acid content of human skeletal muscle in various myopathies. J. Lab. clin. Med. 66, 452 (1965).
Hess, R., and A. G. E. Pearse: Dissociation of uridine diphosphate glucose-glycogen transglucosylase from phosphorylase activity in individual muscle fibers. Proc. Soc. exp. Biol. (N. Y.) 107, 569 (1961).
Heyck, H., G. Laudahn u. C. J. Lüders: Fermentaktivitätsbestimmungen in der gesunden menschlichen Muskulatur und bei Myopathien. II. Enzymaktivitätsveränderungen im Muskel bei Dystrophia musculorum progressiva. Klin. Wschr. 41, 500 (1963).
Heyck, H., G. Laudahn u. C. J. Lüders Fermentaktivitätsbestimmungen in der gesunden menschlichen Muskulatur und bei Myopathien. III. Enzymaktivitätsänderungen im Serum bei Dystrophia musculorum progressiva. Klin. Wschr. 41, 905 (1963).
Heyck, H., G. Laudahn u. C. J. Lüders Fermentchemische Serumbefunde bei Myopathien. In: Myopathien. Hrsg. von R. Beckmann. Stuttgart: G. Thieme 1965, S. 176.
Heyck, H., G. Laudahn u. C. J. Lüders Serum-und Muskelgewebs-Enzymbefunde bei Myopathien, insbesondere Dystrophia musculorum progressiva. Proc. 8th Congr. Neurology, Vienna 1965, Tom. II, p. 505.
Heyck, H., G. Laudahn u. C. J. Lüders, C. J. Lüders, H. Müller-Stephan N, and P. Schmidt-Peter: Anabolic steroids and digitoxin in the treatment of progressive muscular dystrophy. Acta paediat. scand. 54, 205 (1965).
Heyck, H., G. Laudahn u. C. J. Lüders u. P. M. Carsten: Enzymaktivitätsbestimmungen bei Dystrophia musculorum progressiva. IV. Die Serumenzymkinetik im präklinischen Stadium des Typus Duchenne während der ersten 2 Lebensjahre. Klin. Wschr. 44, 695 (1966).
Heyck, H., C. J. Lüders u. G. Laudahn: Beitrag zur Dystrophia musculorum progressiva. V. Histologische Befunde im präklinischen Stadium der Dystrophia musculorum progressiva Typ Duchenne. Klin. Wschr. 44, 813 (1966).
Heyck, H. Abgrenzung der progressiven Muskeldystrophie von den erblichen spinalen Muskelerkrankungen. Mitteilung eines spinalen Krankheitsbildes mit „Riesenmuskelfasern“. In: Progressive Muskeldystrophie, Myotonie, Myasthenie. Hrsg. von E. Kuhn. Berlin-Heidelberg-New York: Springer 1966, S. 120.
Heyck, H. and G. Laudahn: Muscle and serum enzymes in muscular dystrophy and neurogenic muscular atrophy. A comparative study. In: Exploratory Concepts in Muscular Dystrophy and Related Disorders. Edit. by A. T. Milhorat. Excerpta Medica Foundation, Amsterdam, Int. Congr. Ser. 147, 232 (1967).
Hickman, K. C. D., and P. L. Harris: Tocopherol Interrelationships. Advanc. Enzymol. 6, 469 (1946).
Hoagland, C. L., H. Gilder, and R. E. Shank: Synthesis, storage and excretion of creatine, creatinine, and glycocyamine in progressive muscular dystrophy, and the effects of certain hormones on these processes. J. exp. Med. 81, 423 (1945).
Hoagland, C. L. Some biochemical problems posed by a disease of muscle. In: Green’S Currents in Biochemical Research. New York: Interscience 1946, p. 413.
Hoagland, C. L. States of altered metabolism in diseases of muscle. Advanc. Enzymol. 6, 193 (1946).
Hogan, E.L., D. M. Dawson, and F. C. A. Romanul: Enzymatic changes in denervated muscle. II. Biochemical studies. Arch. Neurol. (Chic.) 13, 274 (1965).
Hogue, D. E., J. F. Proctor, R. G. Warner, and J. K. Loosli: Relation of selenium, vitamin E and an unidentified factor to muscular dystrophy (stiff-lamb or white-muscle disease) in the lamb. J. Animal Sci. 21, 25 (1962).
Holliday, T. A., V. S. Asmundson, and L. M. Julian: Plasma creatine phospho-kinase activity of chickens with hereditary muscular dystrophy. Enzym. biol. clin. 5, 209 (1965).
Holloszy, J. O.: Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J. biol. Chem. 242, 2278 (1967).
Holman, R. T., H. Mohrhauer, E. G. Hill, and W. O. Caster: Muscular dystrophy. A problem in polyunsaturated fatty acid metabolism? Amer. J. clin. Nutr. 16, 453 (1965).
Homburger, F., C. W. Nixon, M. Eppenberger, and J. R. Baker: Hereditary myopathy in the Syrian hamster: studies on pathogenesis. Ann. N. Y. Acad. Sci. 138, 14 (1966).
Homburger, F., J. R. Baker, G. F. Wilgram, J. B. Caulfied, and C. W. Nixon: Hereditary dystrophy-like myopathy. The histopathology of hereditary dystrophy-like myopathy in Syrian hamsters. Arch. Path. 81, 302 (1966).
Hooey, M. A., and L. M. Jerry: The cardiomyopathy of muscular dystrophy: Report of two cases with a review of the literature. Canad. med. Ass. J. 90, 771 (1964).
Hooft, C., P. De Laey, and Y. Lambert: Étude comparative de l’activité enzymatique du tissu musculaire de l’enfant normal et d’enfants atteints de dystrophie musculaire progressive aux différents stades de la maladie. Rev. franç. Étud. clin. biol. 11, 510 (1966).
Hooton, B. T., and D. C. Watts: A modified creatine kinase from dystrophic mouse skeletal muscle. Biochem. J. 99, 53 p (1966).
Hooton, B. T., and D. C. Watts Adenosine 5′-triphosphate-creatine phosphotransferase from dystrophic mouse skeletal muscle. A genetic lesion associated with the catalytic-site thiol group. Biochem. J. 100, 637 (1966).
Hooton, B. T., and D. C. Watts Levels of protein and non-protein sulphydryl groups in the skeletal muscle of normal and dystrophic Bar Harbor mice. Clin. chim. Acta 16, 173 (1967).
Horvath, B., L. Berg, D. J. Cummings, and G. M. Shy: Muscular dystrophy. Cation concentrations in residual muscle. J. appl. Physiol. 8, 22 (1955).
Horvath, B. Muscle proteins in dystrophy. Neurology (Minneap.) 8, Suppl. 1, 52 (1958).
Horvath, B. and J. B. Proctor: Muscular dystrophy. Quantitative studies on the composition of dystrophic muscle. Res. Publ. Ass. nerv. ment. Dis. 38, 740 (1960).
Hosein, E. A., E. Powell, G. Perel, and S. Eisenstein: Biochemical changes in rat skeletal muscle following intramuscular injections of the ethyl ester of gamma butyrobetaine. Rev. canad. Biol. 21, 489 (1962).
Hosenfeld, D. J., u. Wiesmann, and R. Richterich: Plasma creatine kinase activity in mice with hereditary muscular dystrophy. Enzym. biol. clin. 2, 246 (1962/63).
Hottinger, A., u. H. Berger: Freie alpha-Aminosäuren in Serum und Urin bei progressiver Muskeldystrophie (eine Familienuntersuchung). In: Myopathien. Hrsg. von R. Beckmann. Stuttgart: G. Thieme 1965, S. 144.
Hughes, B. P.: Studies on the starch gel electrophoresis of some human muscle proteins. Clin. chim. Acta 6, 794 (1961).
Hughes, B. P. Serum enzymes in carriers of muscular dystrophy. Brit. med. J. 1962 II, 963.
Hughes, B. P. Some biochemical aspects of the myopathies. Postgrad. med. J. 41, 313 (1965).
Hughes, B. P. Phospholipids. A biochemical approach to the problem of muscle disease. Curr. Med. Drugs 6, 3 (1966).
Hummel, J. P., and D. H. Basinski: The in vitro effect of tocopherol phosphate on the respiration of muscle from normal and dystrophic rabbits. J. biol. Chem. 172, 417 (1948).
Hummel, J. P. Oxidative phosphorylation processes in nutritional muscular dystrophy. J. biol. Chem. 172, 421 (1948).
Hummel, J. P. and R. S. Melville: Respiration and glycolysis of rabbit muscle in vitamin E-de-ficiency. J. biol. Chem. 191, 391 (1951).
Hunter, A.: Creatine and Creatinine. New York: Lingmans-Green 1928.
Hurley, K. E., and R. J. Williams: Urinary amino acids, creatinine and phosphate in muscular dystrophy. Arch. Biochem. 54, 384 (1955).
Hurwitz, S.: Primary myopathies. Report of 36 cases and review of the literature. Arch. Neurol. (Chic.) 36, 1294 (1936).
Hustrulid, R., and J. Clausen: Lactate dehydrogenase isoenzymes in muscular development of man and in nerve degeneration. Acta neurol. scand. 41, 431 (1965).
Huvos, A. G., and W. Pruzanski: Smooth muscle involvement in primary muscle disease. II. Progressive muscular dystrophy. Arch. Path. 83, 234 (1967).
Ideo, G., P. M. Mannucci, G. Spano, A. Cao A. Macciotta: Gli isoenzimi della malatodeidrogenasi (MDH) del muscolo normale fetale, adulto e di soggetti affetti da distrofia muscolare progressiva tipo Duchenne. Boll. Soc. ital. Biol. sper. 42, 691 (1966).
Ideo, G. A. Cao: Caratterizzazione cromatografica su DEAE-Sephadex della fruttosio-1,6-difosfato aldolasi del muscolo adulto normale, fetale e di soggetti affetti da distrofia muscolare progressiva tipo Duchenne. Boll. Soc. ital. Biol. sper. 42, 693 (1966).
Indovina, I.: Sul ricambio del ferro nei miopatici primitivi comportamento del ferro nel siero nei miopatici e sue variazioni giornaliere. Boll. Soc. ital. Biol. sper. 23, 395 (1947).
Indovina, I. e C. Pattavina: La distribuzione del Fe59 incettato endovena nelle ferroproteine dei soggetti affetti da distrofia muscolare progressiva. Boll. Soc. ital. Biol. sper. 29, 762 (1953).
Indovina, I. Fisiopatologia dei Pentosi nel Sangre. Catania: Ediz. Minerva 1956.
Ionasescu, V., et N. Luca: Contributions à l’étude des modifications électrophorétiques sériques dans les myopathies. Rev. neurol. 102, 253 (1960).
Ionasescu, V., et N. Luca Serum aldolase activity in degenerative neurological diseases. Acta neurol. scand. 38, Suppl. I, 77 (1962).
Ionasescu, V., et N. Luca Investigations on carbohydrate metabolism in progressive muscular dystrophies. Psychiat. et Neurol. (Basel) 146, 309 (1963).
Ionasescu, V., et N. Luca Studies on carbohydrate metabolism in amyotrophic lateral sclerosis and hereditary proximal spinal muscular atrophy. Acta nourol. scand. 40, 47 (1964).
Ionasescu, V., et N. Luca Studies on carbohydrate metabolism in muscular diseases in conditions of ischaemic work. Psychiat. et Neurol. (Basel) 149, 375 (1965).
Ionasescu, V., et N. Luca Étude de l’aldolase sérique dans les familles des myopathes. Considérations de génétique biochimique. Rev. roum. Neurol. 3, 217 (1966).
Ionasescu, V., et N. Luca Espace extracellulaire et assimilation du glucose dans les myopathies et les affections neurogènes amyotrophinantes. Psychiat. et Neurol. (Basel) 151, 328 (1966).
Iwashita, H., and Y. Ohta: Serum-creatine-phosphokinase levels. Lancet 1967 I, 621.
Jacina, J., E. Mathéova, V. Tischler, C. Horak u. M. Komoras: Serum-Enzyme bei Müttern während der Geburt und bei Neugeborenen. I. Aktivität der Serum-Transaminasen für Glutamat-Oxalazetat und Glutamat-Pyruvat. Zbl. Gynäk. 87, 967 (1965).
Jackson, A., and M. J. O’Donnell: Progressive muscular dystrophy with 1: 1 atrial flutter. Amer. Heart J. 59, 277 (1960).
Jackson, C. E., and W. D. Block: Pyelonephritis and hypertension in unilateral renal disease. J. Lab. clin. Med. 48, 820 (1956).
Jackson, C. E. and J. H. Carey: Progressive muscular dystrophy: autosomal recessive type. Pediatrics 28, 77 (1961).
Jacob, W., u. J. Neuhaus: Die Aktivität der Serumaldolase bei der progressiven Muskeldystrophie (Erb). Klin. Wschr. 32, 923 (1954).
Jacobi, H. P., S. Rosenblatt, V. M. Wilder, and S. Morgulis: Enzyme studies on rabbits with incipient muscle dystrophy. Arch. Biochem. 27, 19 (1950).
Jacobs, H., H. W. Heldt, and M. Klingenberg: High activity of creatine kinase in mitochondria from muscle and brain and evidence for a separate mitochondrial isoenzyme of creatine kinase. Biochem. biophys. Res. Commun. 16, 516 (1964).
James, Th. N.: Observations on the cardiovascular involvement, including the cardiac conduction system, in progressive muscular dystrophy. Amer. Heart J. 63, 48 (1962).
Janaki, S., and A. K. Susheela: Enzyme histochemistry of muscle, with special reference to the Duchenne type of muscular dystrophy (A preliminary communication). Neurology (Bombay) 14, 174 (1966).
Jannet, N. W., S. P. Goodhart, and V. I. Isaacson: The endocrine origin of muscular dystrophy. Arch. intern. Med. 21, 188 (1918).
Jasmin, G., et M. Grégoire: Étude histochimique des lésions musculaires dans divers types de myopathies. Neuro-chirurgie 10, 465 (1964).
Jenkins, K. J.: Ketone body metabolism in nutritional myopathy. Canad. J. Biochem. 42, 1153 (1964).
Jerusalem, F.: Die bioptisch-histologische Differential-Diagnose der Polymyositis und der progressiven Muskeldystrophie. Dtsch. Z. Nervenheilk. 191, 125 (1967).
Johnston, H.A., J.H. Wilkinson, W.A. Withycombe et al.: Alpha-hydroxybutyrate dehydrogenase activity in sex-linked muscular dystrophy. J. clin. Path. 19, 250 (1966).
Jordan, J. P., F. H. Kratzer, and N. S. Zarghami: Lipid composition of the pectoral muscles of chickens with inherited muscular dystrophy. Proc. Soc. exp. Biol. (N. Y.) 116, 243 (1964).
Julian, L. M., and V. S. Asmundson: Anatomical expression of genes of muscular dystrophy in heterozygous chickens. Anat. Rec. 136, 218 (1960).
Julian, L. M., and V. S. Asmundson Muscular dystrophy of the chicken. In: Muscular Dystrophy in Man and Animals. Edit. by G. H. Bourne and N. Golarz. New York: Hafner 1963, p. 458.
Jungbeck, H.: Die Bedeutung der Serumcholinesterase. Die Beziehungen der Serum-cholinesterase, der Pantothensäure und des Methionine zur Antikörperbildung. Dissertation, München 1952.
Kabara, J. J.: Brain cholesterol. V. Effect of hereditary dystrophia muscularis on acetate incorporation. Tex. Rep. Biol. Med. 22, 126 (1964).
Kabara, J. J. Brain cholesterol. VI. The effect of hereditary dystrophia muscularis on (C 14) leucine and (2-3 H) acetate incorporation. Tex. Rep. Biol. Med. 22, 134 (1964).
Kabara, J. J. Brain cholesterol. VII. The effect of hereditary dystrophia muscularis on (2-14 C) mevalonic and (2-3 H) acetate incorporation. Tex. Rep. Biol. Med. 22, 143 (1964).
Kaboth, W.: Zur Pathomorphologie der Myopathien und über einen Fall von Herzbeteiligung bei progressiver Muskeldystrophie. Med. Welt (Stuttg.) 1963, 1302.
Kaeser, H. E.: Das Verhalten der Serum-Glutamat-Oxalacetat-Transaminase bei Myopathien und neurogenen Muskelatrophien. Dtsch. Z. Nervenheilk. 179, 353 (1959).
Kaeser, H. E. Serum-Transaminasebestimmungen bei der progressiven Muskeldystrophie mit besonderer Berücksichtigung der Untergruppen von Becker. Ann. paediat. (Basel) 195, 1 (1960).
Kaldor, G., and J. Gitlin: ATPase, myokinase, 5′adenylic acid deaminase activity and syneresis of the dystrophic mouse. Proc. Soc. exp. Biol. (N. Y.) 113, 802 (1963).
Kandutsch, A. A., and A. E. Russell: Creatine and creatinine in tissues and urine of mice with hereditary muscular dystrophy. Amer. J. Physiol. 194, 553 (1958).
Kaplan, N. O., and R. D. Cahn: Lactic dehydrogenases and muscular dystrophy in chicken. Proc. nat. Acad. Sci. (Wash.) 48, 2123 (1962).
Kar, N. C., and C. M. Pearson: Developmental changes and heterogeneity of lactic and malic dehydrogenases of human skeletal muscles and other organs. Proc. nat. Acad. Sci. (Wash.) 50, 995 (1963).
Kar, N. C., and C. M. Pearson Glutamic oxalacetic transaminase isoenzymes in human myopathies. Proc. Soc. exp. Biol. (N. Y.) 116, 733 (1964).
Kar, N. C., and C. M. Pearson Creatine phosphokinase isoenzymes in muscle in human myopathies. Amer. J. clin. Path. 43, 207 (1965).
Kar, N. C., and C. M. Pearson Activation of creatine phosphokinase by sulfhydryl compounds in normal and muscular dystrophy sera. Proc. Soc. exp. Biol. (N. Y.) 118, 662 (1965).
Kare, M. R.: Phosphocreatine in red and white muscle. Proc. Soc. exp. Biol. (N. Y.) 77, 692 (1951).
Katz, A. M., and W. Kalow: Abnormal isoenzyme patterns in human myopathies. Nature (Lond.) 209, 1349 (1966).
Kelly, S., W. Kelly, and H.L. Swift: Serum creatine phosphokinase in four generations of a muscular dystrophy family. Amer. J. clin. Path. 45, 377 (1966).
Kendrick-Jones, J., and S. V. Perry: Enzymatic adaptation to contractile activity in skeletal muscle. Nature (Lond.) 208, 1068 (1965).
Kendrick-Jones, J., and S. V. Perry Protein synthesis and enzyme response to contractile activity in skeletal muscle. Nature (Lond.) 213, 406 (1967).
Kessler, G., M. B. Hermel, and J. Gershon-Cohen: Serum glutamic oxaloacetic transaminase activity after whole body irradiation. Proc. Soc. exp. Biol. (N. Y.) 98, 201 (1958).
Kibrick, A. C., C. Q. Hashiro, R. S. Schutz, M. I. Walters, and A. T. Milhorat: Prolylhydroxyproline in urine: Its determination and observations in muscular dystrophy. Clin. chim. Acta 10, 344 (1964).
Kilburn, K. H., J. Eagan, H. Sieker, and A. Heyman: Cardiopulmonary insufficiency in myotonic and progressive muscular dystrophy. New Engl. J. Med. 261, 1089 (1959).
Kivirikko, K. I., and O. Laitinen: Clinical significance of urinary hydroxyproline determinations in children. Ann. paediat. Fenn. 11, 148 (1965).
Kleine, T. O., u. H. Chlond: Zur Pathogenese der progressiven Muskeldystrophie (Erb). Med. Klin. 59, 641 (1964).
Kleine, T. O. Zur Lokalisation der Creatinkinase (CK) in Mitochondrien und Mikrosomen von Skeletmuskel, Herz und Hirnrinde des Menschen. Klin. Wschr. 43, 504 (1965).
Kleine, T. O. u. H. Chlond: NADHP-und NADH-spezifische Glutathionreduktase (Gssgr)-Aktivität im Serum und Muskel von Muskeldystrophikern (Erb). Clin. chim. Acta 13, 407 (1966).
Kleine, T. O. u. H. Chlond Die Aktivität der Myokinase (Adenylatkinase) und der Creatinkinase im Serum und Muskel bei der progressiven Muskeldystrophie (Erb). Klin. Wschr. 44, 103 (1966).
Kleine, T. O. u. H. Chlond Enzymmuster gesunder Skelett-, Herz-und glatter Muskulatur des Menschen sowie ihrer pathologischen Veränderungen mit besonderer Berücksichtigung der progressiven Muskeldystrophie (Erb). Clin. chim. Acta 15, 19 (1967).
Kleine, T. O. Enzymmuster gesunder und pathologisch veränderter Muskeln des Menschen. Z. klin. Chem. 5, 244 (1967).
Knoll, P.: Über protoplasmaarme und protoplasmareiche Muskulatur. Denkschr. Wiss. Wien. math.-nat. Kl. 58, 633 (1891).
Knowlton, G. C., and H. M. Hines: The respiratory metabolism of atrophic muscle. Amer. J. Physiol. 109, 200 (1934).
Kolb, P., u. C. S. So: Serum-Enzyme (GOT, GPT, LDH, CPK, ALD) bei Friedreich-scher Ataxie. Klin. Wschr. 42, 1246 (1964).
Kondo, F.: Clin. Neurol. 5, 695 (1965).
Kondo, F., E. Abe, M. Ikeda, and S. Mue: Occasional appearance of diphosphopyridine nucleotide in urine of patients with progressive muscular dystrophy. Tohoku J. exp. Med. 91, 191 (1967).
Konieczny, L., J. Noworytko u. M. Sarnecka-Keller: Untersuchungen über die chemische Symptomatologie der progressiven Muskeldystrophie. Pol. Arch. Med. wewnet. 28, 1579 (1958).
Korting, G. W., G. Weber u. H. Werle: Enzympathologische Beobachtungen bei Dermatomyositis. Hautarzt 13, 485 (1962).
Koszalka, T. R.: Relation of vitamin E to proteolytic and autolytic activity of skeletal muscle. J. Nutr. 73, 78 (1961).
Kove, S., S. Goldstein, and F. Wroblewski: Activity of glutamic-oxaloacetic transaminase in the serum in the neonatal period. Pediatrics 20, 584 (1957).
Kove, S., S. Goldstein, and F. Wroblewski Measurement of activity of transaminases in the serum as an aid in differential diagnosis of jaundice in the neonatal period. Pediatrics 20, 590 (1957).
Krieg, U., u. E. Kirsten: Freie Aminosäuren im roten und weißen Muskel vom Kaninchen. Biochem. Z. 341, 543 (1965).
Krüger, P., F. Duspiva u. F. Furlinger: Tetanus und Tonus der Skeletmuskeln des Frosches, eine histologische, reizphysiologische und chemische Untersuchung. Arch. Physiol. 231, 750 (1933).
Kruh, J., J. C. Dreyfus, G. Schapira, and G. O. Get: Abnormalities of muscle protein metabolism in mice with muscular dystrophy. J. clin. Invest. 39, 1180 (1960).
Krupnick, A. B., C. M. Casa, and H. Rosenkrantz: Nucleic acid content in nutritional muscular dystrophy. Arch. Biochem. 106, 89 (1964).
Kryschowa, N., u. W. Abowjan: Zur Frage der Heredität der Pseudohypertrophie Duchenne. Z. ges. Neurol. Psychiat. 150, 421 (1934).
Kudo, A.: Studies on muscle phosphorylase activity in progressive muscular dystrophy. J. Jap. Orthop. Ass. 38, 951 (1965).
Küstner, W., A. Paetzel u. J. Weinreich: Veränderungen der Kreatinphospho-kinase-Aktivität im Serum bei körperlicher Belastung. Med. Klin. 61, 1858 (1966).
Kuhlbäck, B.: Creatine and creatinine metabolism in thyrotoxicosis and hypothyroidism. Acta med. scand. 159, Suppl. 331, 1 (1957).
Kuhn, E., u. W. Wörner: Die Serum-Transaminasen bei Patienten mit myotonischer Dystrophie. Z. klin. Med. 155, 544 (1959).
Kuhn, E. Aldolase-Bestimmungen im Serum bei myotonischer Dystrophie. Klin. Wschr. 37, 236 (1959).
Kuhn, E. u. W. Wörner: Intermediärstoffwechseluntersuchungen bei myotonischer Dystrophie. Milchsäure, Brenztraubensäure, Milchsäuredehydrogenase und Äpfelsäuredehydrogenase. Nervenarzt 32, 182 (1961).
Kuhn, E. Endokrinologische Untersuchungen bei myotonischer Dystrophie. Endokrinologie 41, 153 (1961).
Kuhn, E. Endokrinologische Untersuchungen bei myotonischer Dystrophie. Endokrinologie 41, 307 (1961).
Kuhn, E., H. G. Stehlin u. W. Stein: Kreatinphosphokinase (CPK) im Serum bei myotonischer Dystrophie. Klin. Wschr. 40, 741 (1962).
Kuhn, E. Muskelerkrankungen und Aktivität der Aldolase, der Glutamat-Oxalacetat-Trans-aminase (GOT), Glutamat-Pyruvat-Transaminase (GPT), Laktatdehydrogenase (LDH) und der Kreatinphosphokinase (CPK) im Serum. In: Medizin und Ernährung, aus: Bedeutung und Grenzen der Enzymdiagnostik im Serum. Lochham: Pallas-Verlag 1964, S. 3.
Laet, P. De: Certains mécanismes biochimiques de la dystrophic musculaire progressive. Arch. franç. Pédiat. 22, 130 (1965).
Laferte, R. O., H. Rosenkrantz, and L. Berlinguet: Transamination in muscular dystrophy and the effect of exogenous glutamate. A study of vitamin E-deficient rabbits and mice with hereditary dystrophy. Canad. J. Biochem. 41, 1423 (1963).
Laguens, R.: Satellite cells of skeletal muscle fibers in human progressive muscular dystrophy. Virchows Arch. path. Anat. 336, 564 (1963).
Laird, J. L., and R. F. Timmer: Homotransplantation of dystrophic and normal muscle. Arch. Path. 80, 442 (1965).
Lambert, Y.: Stade préclinique de la dystrophic musculaire progressive. Arch. franç. Pédiat. 22, 129 (1965).
Lamy, M., et J. De Grouchy: L’hérédité de la myopathie (Formes basses). J. Génét. hum. 3, 219 (1954).
Lapan, B., and M. M. Friedman: A comparative study of fetal and maternal serum enzyme levels. J. Lab. clin. Med. 54, 417 (1959).
Lapresle, L.: Microscopie électronique. Sur un type particulier de disposition myo-fibrillaire observé au microscope électronique dans un cas d’amyotrophie Charcot-Marie-Tooth. C. R. Soc. Biol. (Paris) 159, 568 (1965).
Laron, Z., and A. Kowadlo: Fat-mobilizing effect of testosterone. Metabolism 12, 588 (1963).
Laron, Z., and A. Kowadlo Further evidence for all fat mobilizing effect of androgens. Acta endocr. (Kbh.) 45, 427 (1964).
Laudahn, G.: Fermentaktivitäten und Konzentration von Stoffwechselzwischen-produkten im Blut bei Leber-und Herzkrankheiten. Klin. Wschr. 37, 850 (1959).
Laudahn, G. Tierexperimentelle und biochemische Untersuchungen zur Ursache der gesteigerten Fermentaktivität im Blut bei Leberkrankheiten. Z. Ges. exp. Med. 132, 346 (1959).
— Zur Biochemie der progressiven Muskeldystrophie. Vergleichende enzymatische Untersuchungen in Skeletmuskulatur, Serum und Vollblut von Gesunden und Patienten mit progressiver Muskeldystrophie. Habilitationsschrift, Freie Universität Berlin 1963.
Laudahn, G. u. H. Heyck: Fermentaktivitätsbestimmungen in der gesunden menschlichen Muskulatur und bei Myopathien. I. Enzymmuster und intracellulär Verteilung von Enzymen im gesunden Skeletmuskel. Klin. Wschr. 41, 493 (1963).
Laudahn, G. Bestimmung der Glutaminsäure-Dehydrogenase-Aktivität im Serum bei verschiedenen inneren Krankheiten. Klin. Wschr. 41, 618 (1963).
Laudahn, G. Fortschritte und Grenzen der klinischen Serumenzymdiagnostik. Berl. Med. 15, 701 (1964).
Laudahn, G. u. H. J. Mallach: Untersuchungen zur postmortalen Aktivität von Hauptkettenenzymen in menschlicher Skeletmuskulatur. Klin. Wschr. 43, 959 (1965).
Laudahn, G. u. H. Heyck: Muskelenzymbefunde bei progressiver Muskeldystrophie. In: Myopathien. Hrsg. von R. Beckmann. Stuttgart: G. Thieme 1965, S. 165.
Laudahn, G. Zur Biochemie der progressiven Muskeldystrophie. Fortschr. Med. 84, 429 (1966).
Laudahn, G., H. Heyck u. F. Feustel: Enzyme im Serum bei Muskelkrankheiten. In: Praktische Enzymologie. Grundlagen, Gesichertes und Grenzen. Hrsg. von F. W. Schmidt. Bern u. Stuttgart: Huber 1968, S. 249.
Laurent, R., J. C. Dreyfus et G. Schapira: Électrophorèse de myoglobines. Influence de la section nerveuse. Bull. Soc. Chim. biol. (Paris) 43, 416 (1961).
Lauryssens, M. G., M. J. Lauryssens, and H. A. Zondag: Electrophoretic distribution pattern of lactate dehydrogenase in mouse and human muscular dystrophy. Clin. chim. Acta 9, 276 (1964).
Leipert, T., u. T. Wanko: Zur Frage der Hypoxie bei progressiver Muskeldystrophie. Acta neuroveg. (Wien) 13, 93 (1956).
Leonard, S. L.: Phosphorylase and glykogen levels in skeletal muscle of mice with hereditary myopathy. Proc. Soc. exp. Biol. (N. Y.) 96, 720 (1957).
Leulier, A., et B. Pomme: Sur le taux du potassium musculaire à l’état normal et dans quelques affections neurologiques. C. R. Soc. Biol. (Paris) 109, 743 (1932).
Leulier, A., et B. Pomme et A. Bernard: Recherches sur le taux du potassium musculaire chez l’homme. C. R. Soc. Biol. (Paris) 119, 201 (1935).
Levene, P. A., and L. Kristeller: Factors regulating the creatinin output in man. Amer. J. Physiol. 24, 45 (1909).
Levi, M., e N. D’eramo: Studio sulle malattie neuromuscolari. Osservazioni sul comportamento dei sistemi endocrino e neurovegetativo. Rass. clin.-sci. Ist. biochim. ital. 34, 111 (1958).
Levin, S., G. S. Baens, and T. Weinberg: The heart in pseudohypertrophic muscular dystrophy. J. Pediat. 55, 460 (1959).
Leyburn, P., W. H. Thomson, and J. N. Walton: An investigation of the carrier state in the Duchenne type muscular dystrophy. Ann. hum. Genet. 25, 41 (1961).
Lieberman, J., I. I. Lasky, S. I. Dulkin, and O. E. Lobstein: Serum glutamic oxaloacetic transaminase activity in conditions associated with myocardial infarction. 1. Bodily trauma. 2. Cerebral vascular accidents and congestive heart failure. Ann. intern. Med. 46, 405, 497 (1957).
Lilienthal, J. L., and K. L. Zierler: Diseases of muscle. In: Biochemical Disorders in Human Disease. Edit. by R. H. S. Thompson and E. J. King. New York: Academic Press 1957, p. 445.
Lindsay, D. T.: Isozymic patterns and properties of lactate dehydrogenase from developing tissues of the chicken. J. exp. Zool. 152, 75 (1963).
Ling, G.: Muscle electrolytes. Amer. J. phys. Med. 34, 89 (1955).
Löwenthal, A., et M. Van Sande: Application de la microélectrophorèse sur papier à l’étude des protéines sériques chez des patients atteints d’affections musculaires. Acta neurol. belg. 54, 864 (1954).
Löwenthal, A., et M. Van Sande Nouvelles déterminations de fractions protéiniques dans le sérum de patients atteints d’affections musculaires. Rev. franç. Étud. clin. biol. 1, 765 (1956).
Löwenthal, A., et M. Van Sande and D. Karcher: Heterogeneity of lactic and malic dehydrogenase in serum, cerebrospinal fluid, and brain extracts in man and sheep. Ann. N. Y. Acad. Sci. 94, 988 (1961).
Löwenthal, A., D. Karcher, M. Van Sande et M. Wintgens: Distribution des isoenzymes de la lactico-déhydrogénase dans le cerveau du fœtus humain et dans le liquide céphalorachidien du nouveau-né. Acta neurol. belg. 66, 553 (1966).
Louw, A., and H. E. Nielsen: Paroxysmal hemoglobinuria. Acta med. scand. 117, 424 (1944).
Lowenstein, A. S., S. R. Arbeit, and I. L. Rubin: Cardiac involvement in progressive muscular dystrophy. An electrocardiographic and ballistocardiographic study. Amer. J. Cardiol. 9, 528 (1962).
Lucas, G. J., and F. M. Forster: Charcot-Marie-Tooth disease with associated myopathy. A report of a family. Neurology (Minneap.) 12, 629 (1962).
Luckner, H.: Experimentelle E-Avitaminose — Modell von Myopathien? Dtsch. Z. Nervenheilk. 173, 525 (1955).
Ludwig, O., u. I. Warlamidis: Myocardläsion bei Dystrophia musculorum progressiva Erb. Wien. med. Wschr. 117, 271 (1967).
Luzzatto, A., e G. Casirola: Rilievi sulla attivita fosfatasiche seriche insoggetti affetti da distrofia muscolare progressiva. Riv. Pat. nerv. ment. 75, 357 (1954).
Luzzatto, A. e M. Lodigiani: Rilievi sul significato della iperpiruvicemia nella distrofia muscolare progressiva. Minerva med. 45, 725 (1954).
Luzzatto, A. E. Ramelli: L’iperpiruvicemia nella distrofia muscolare progressiva a una caratteristica genica? Cervello 35, 377 (1959).
Lyon, M.: Gene action in the X-chromosome of the mouse. Nature (Lond.) 190, 372 (1961).
Lyon, M. Sex chromatin and gene action in the mammalian X-chromosome. Amer. J. hum. Genet. 14, 135 (1962).
Macciotta, A., A. Cao: Contributo alla conoscenza della distrofia muscolare progressiva con particolare riguardo agli aspetti metabolici ed etiopatogenetici. Ann. ital. Pediat. 10, 173 (1957).
Macciotta, A., A. Cao e V. Scano: Ann. ital. Pediat. 18, 14 (1965).
Madsen, L. L.: The comparative effects of cod liver oil, cod liver oil concentrate, lard, and cottonseed oil in a synthetic diet on the development of nutritional muscular dystrophy. J. Nutr. 11, 471 (1936).
Manning, G. W., and G. J. Cropp: The electrocardiogram in progressive muscular dystrophy. Brit. Heart J. 20, 416 (1958).
Mannino, V., A. Notarbartolo, and L. Pagliaro: Action of galanthamine on various laboratory tests in subjects with progressive muscular dystrophy. Clin. ter. 23, 938 (1962).
Marandola, G.: Glutamic-oxalacetic transaminase activity in patients with myopathy. Cervello 38, 374 (1962).
Marchand, J. F.: Genetic variations in muscular enzyme systems. Review of research and its clinical application. Arch. phys. Med. 47, 147 (1966).
Markert, C. L., and H. Ursprung: The ontogeny of isozyme patterns of lactate dehydrogenase in the mouse. Develop. Biol. 5, 363 (1962).
Markert, C. L. Lactate dehydrogenase isozymes. Dissociation and recombination of subunits. Science 140, 1329 (1963).
Martoni, L., e S. Musiani: Variazioni dell’attivita aldolasica serica nell’eta neonatale in condizioni fisiologiche, parafisiologiche e patologiche. Clin. pediat. (Bologna) 40, 397 (1958).
Mason, K. E.: Experimental muscular dystrophy. Proc. 1st Med. Conf. Musc. Dystr. Ass. America, New York 1951, p. 25.
—, M. Y. Dju, and S. J. Chapin: Vitamin E-content of tissues in progressive muscular dystrophy. Proc. Musc. Dystr. Ass. 1952, 94.
Massarrat, S.: Über den Einfluß operativer Eingriffe am Gallenwegssystem, besonders bei Lebererkrankungen, auf den Serumspiegel der Enzyme Sorbitdehydrogenase, Glutamat-Pyruvat-Transaminase, Laktatdehydrogenase und Glutamatdehydrogenase. Acta hepato-splenol. (Stuttg.) 9, 86 (1962).
Mathur, K. S., and D. S. Garlaut: Serum GOT in muscular dystrophy and neuromuscular diseases. J. Indian med. Ass. 33, 168 (1959).
Matsumura, Y., T. Mimura, and S. Sumita: Effect of anserine and carnosine on phosphorus metabolism in skeletal muscle. Symp. Enzyme Chemistry 15, 132 (1963).
Matthews, W. B., and M. J. H. Smith: Ribosuria in muscular dystrophy. J. Neurol. Neurosurg. Psychiat. 16, 184 (1953).
Matzelt, D., u. H. G. Mertens: Enzymverteilungsmuster im menschlichen Muskelgewebe. Verh. Dtsch. Ges. Inn. Med. 68. Kongr. München: J. F. Bergmann 1962, S. 285.
Matzelt, D. u. K. H. Vosteen: Elektronenoptische und enzymatische Untersuchungen an menschlicher Kehlkopfmuskulatur. Arch. Ohr.-, Nas.-u. Kehlk.-Heilk. 181, 447 (1963).
Mayers, G. L., and N. Epstein: Evaluation of glycolytic and citric acid cycles in homogenates of dystrophic mouse muscle. Proc. Soc. exp. Biol. (N. Y.) 111, 450 (1962).
McArdle, B.: Biochemical investigations in muscle disease. In: Research in Muscular Dystrophy. London: Pitman 1963, p. 145.
— Biochemical findings in neuro-muscular disorders. Proc. 8th Int. Congr. Neurology, Vienna 1965, Tom. II, p. 103.
McCaman, M. W.: Dehydrogenase activities in dystrophic mice. Science 132, 621 (1960).
McCaman, M. W. Enzyme studies of skeletal muscle in mice with hereditary muscular dystrophy. Amer. J. Physiol. 205, 897 (1963).
McCaman, M. W., M. L. Stafford, and E.-C. Skinner: Choline acetyltransferase and cholinesterase activities in muscle of dystrophic mice. Amer. J. Physiol. 212, 228 (1967).
McCrudden, R. H., and C. S. Sargent: Hypoglycemia and progressive muscular dystrophy. Arch. intern. Med. 17, 465 (1916).
McGaughey, C.: Excretion of α-ketoglutarate, urea and amino acids by normal and muscular dystrophic mice. Proc. Soc. exp. Biol. (N. Y.) 103, 730 (1960).
McGeer, P. L., E. G. McGeer, and M. C. Griffin: Excretion of 4-amino-5-imidazole-carboxamide in human urine. Canad. J. Biochem. 39, 591 (1961).
McGeer, E. G., P. L. McGeer, J. R. Miller, D. Derry, and C. Nichol: Excretion of 4-amino-5-imidazolecarboxamide and creatine: creatine rations in human and mouse muscular dystrophy. Canad. J. Biochem. 40, 13 (1962).
McLean, J. R., G. L. Cohn, I. K. Brandt, and M. V. Simpson: Incorporation of labeled amino acids into the protein of muscle and liver mitochondria. J. biol. Chem. 233, 657 (1958).
Meier, H., W. T. West, and W. G. Hoag: Preclinical histopathology of mouse muscular dystrophy. Arch. Path. 80, 165 (1965).
Meier, H. Histochemical observations in preclinical mouse muscular dystrophy. Amer. J. Path. 50, 691 (1967).
Meldolesi, G.: Pathologie und Therapie der progressiven Muskeldystrophie. Dtsch. med. Wschr. 163, 1654 (1937).
Meldolesi, G., W. Siedel u. H. Möller: Über Myobilin. I. Hoppe-Seylers Z. physiol. Chem. 259, 137 (1939).
Meldolesi, G. Rapporti fra ricambio glicidico, attivita insulinica e alterazioni sistemiche della muscolatura striata. II. Ricambio glicidico ed attivita insulinica nelle miopatie, primitive e secon. Boll. Soc. ital. Biol. sper. 25, 914 (1949).
Melloni, G., E. Saurgnani, and G. Dodesini: Clinical contribution to the study of primary and secondary myopathies and some neuromyopathies. Arch. Sci. med. 113, 131 (1962).
Melville, R. S., and J. P. Hummel: Creatine and glycocyamine metabolism in rabbits in vitamin E-deficiency. J. biol. Chem. 191, 383 (1951).
Menkes, J. H., F. Richardson, and S. Verplanck: Program for the detection of metabolic diseases. Arch. Neurol. (Chic.) 6, 462 (1962).
Menne, F., u. R. Beckmann: Der Kreatinstoffwechsel bei Kindern mit Dystrophia musculorum progressiva Erb. Klin. Wschr. 33, 556 (1955).
Menne, F. Der Kreatinhaushalt bei der progressiven Muskeldystrophie und verschiedenen Stoffwechselstörungen. In: Myopathien. Hrsg. von R. Beckmann. Stuttgart: G. Thieme 1965, S. 108.
Mertens, H. G.: Muskeldystrophie, Polymyositis und Muskelatrophie. Dtsch. med. Wschr. 90, 575 (1965).
Mertens, H. G. u. W. C. Globig: Der diagnostische Wert von Serumenzymaktivitätsbestimmungen bei Muskelkrankheiten. Dtsch. med. Wschr. 90, 1177 (1965).
Mertens, H. G., B. Möbius u. J. Möbius: Die Differentialdiagnose der Muskeldystrophien. Internist (Berl.) 7, 175 (1966).
Metz, K. O.: Die Bedeutung der CPK-Bestimmung im Serum bei Kindern. Dissertation, Göttingen 1963.
Michelson, A. M., E. S. Russell, and P. J. Harman: Dystrophia muscularis. A hereditary primary myopathy in the house mouse. Proc. nat. Acad. Sci. (Wash.) 41, 1079 (1955).
Milch, L. J., and H. G. Albaum: Serum transaminase activity in X-irradiated rabbits. Proc. Soc. exp. Biol. (N. Y.) 93, 595 (1956).
Milhorat, A. T., and H. G. Wolff: Metabolism of creatine and creatinine in muscle disease. Ann. intern. Med. 9, 834 (1934).
Milhorat, A. T., and H. G. Wolff Studies in diseases of muscle. I. Metabolism of creatine and creatinine in progressive muscular dystrophy. Arch. Neurol. (Chic.) 38, 992 (1937).
Milhorat, A. T., and H. G. Wolff Studies in diseases of muscle. II. Effect of varying amounts of ingested creatine on creatine tolerance in progressive muscular dystrophy. Arch. Neurol. (Chic.) 39, 37 (1938).
Milhorat, A. T., and H. G. Wolff Studies in diseases of muscle. III. Metabolism of creatine and creatinine in myasthenia gravis, including study of excretion of nucleosides and nucleotides. Arch. Neurol. (Chic.) 39, 354 (1938).
Milhorat, A. T., and H. G. Wolff Studies in diseases of muscle. IV. Metabolism of creatine and creatinine in muscular wastings subsequent to disease of the nervous system. Arch. Neurol. (Chic.) 40, 663 (1938).
Milhorat, A. T., and H. G. Wolff Studies in diseases of muscle. V. Metabolism of creatine and creatinine in myotonia congenita, myotonia atrophica, amyotonia congenita, dystonia musculorum deformans, and paralysis agitans. Arch. Neurol. (Chic.) 40, 680 (1938).
Milhorat, A. T. and V. Toscani: Studies in diseases of muscle. VIII. Metabolism of calcium, phosphorus and magnesium in progressive muscular dystrophy, myotonia atrophica and familial periodic paralysis. Arch. Neurol. (Chic.) 41, 1130 (1939).
Milhorat, A. T., F. C. Weber, and V. Toscani: Metabolic studies in dermatomyositis with a note on the effect of wheat germ. Proc. Soc. exp. Biol. (N. Y.) 43, 470 (1940).
Milhorat, A. T. and W. E. Bartels: Defect of utilization of tocopherol in progressive muscular dystrophy. Science 101, 93 (1945).
Milhorat, A. T. Creatine and creatinine metabolism and diseases of the neuro-muscular system. Res. Publ. Ass. nerv. ment. Dis. 32, 400 (1953).
Milhorat, A. T. Therapy in muscular dystrophy. Med. Ann. D. C. 23, 15 (1954).
Milhorat, A. T. and L. Goldstone: The carrier state in muscular dystrophy of the Duchenne type. J. Amer. med. Ass. 194, 130 (1965).
Milhorat, A. T. S. A. Shafiq, and L. Goldstone: Changes in muscle structure in dystrophic patients, carriers and normal siblings seen by electron microscopy; correlation with levels of serum creatinephosphokinase (CPK). Ann. N. Y. Acad. Sci. 138, 246 (1966).
Milman, A. E., and A. T. Milhorat: Metabolic patterns in experimentally induced muscular dystrophy. Proc. Soc. exp. Biol. (N. Y.) 84, 654 (1953).
— Metabolism of glycogen in experimental muscular dystrophy. Proc. 3rd Med. Conf. Musc. Dystr. Ass. America, New York 1954, p. 291.
Mink, J. K., and H. M. Greebe: Fructo-aldolase in relation to muscular dystrophies. Acta neurol. scand. 40, 107 (1964).
Minot A. S.: The determination of tocopherol in blood serum. J. Lab. clin. Med. 29, 772 (1944).
Minot A. S., H. E. Frank, and D. Dziewiatkowski: The occurrence of pentose and phosphorus containing complexes in the urine of patients with progressive muscular dystrophy. Arch. Biochem. 20, 394 (1949).
Mittelbach, F.: Die Begleitmyopathie bei neurogenen Atrophien. Berlin-Heidelberg-New York: Springer 1966.
Miyoshi, K., K. Saijo, Y. Kuryu, and Y. Oshima: Abnormal myoglobin ultraviolet spectrum in Duchenne Type of progressive muscular dystrophy. Science 142, 490 (1963).
Möbius, W., A. Bonow u. H. Rennecke: Untersuchungen über das Verhalten einiger Serumfermente während des Zyklus. Zbl. Gynäk. 85, 1337 (1963).
Mölbert, E.: Das elektronenmikroskopische Bild des Skeletmuskels bei Dystrophia musculorum progressiva. Naturwissenschaften 47, 186 (1960).
Mölbert, E. u. H. Marx: Elektronenmikroskopische Befunde bei Myopathien. In: Myopathien. Hrsg. von R. Beckmann. Stuttgart: G. Thieme 1965, S. 89.
Mönch, E., E. Kirsten u. H. Heyck: Freie Aminosäuren in Skeletmuskulatur, Vollblut und Urin von Gesunden und von Patienten mit progressiver Muskeldystrophie. Mschr. Kinderheilk. 115, 288 (1967).
Moggi, P., L. Grancalancia e F. Rapi: Il dosaggio elettroforetico délie protéine, lipoprotéine e glicoproteine seriche nelle miopatie. Minerva pediat. 7, 439 (1955).
Molander, D., M. Friedman, and J. S. Ladue: Serum cholinesterase in hepatic and neoplastic diseases. A preliminary report. Ann. intern. Med. 41, 1139 (1954).
Monckton, G., and B. Ludvigsen: The identification of carriers in Duchenne muscular dystrophy. Canad. med. Ass. J. 89, 333 (1963).
Monckton, G. and T. Nihei: Some biochemical changes occurring in muscular dystrophy and their possible genetical significance. Ann. N. Y. Acad. Sci. 138, 329 (1966).
Morey, K. S., K. Tarczy-Hornoch, E. G. Richards, and W. D. Brown: Myosin from dystrophic and control chicken muscle. I. Preparation and preliminary characterization. Arch. Biochem. 119, 491 (1967).
Morgan, D. F., and H. Herrmann: Comparison of muscle tissue from normal and dystrophic chick at different stages of development. Proc. Soc. exp. Biol. (N. Y.) 120, 68 (1965).
Morgulis, S., and H.C. Spencer: Study of dietary factors concerned in nutritional muscular dystrophy. J. Nutr. 11, 573 (1936).
Morgulis, S., V. M. Wilder, H. C. Spencer, and S. H. Eppstein: Studies on the lipid content of normal and dystrophic rabbits. J. biol. Chem. 124, 755 (1938).
Morgulis, S. and H. P. Jacobi: Perspective of biochemical defects in muscle in vitamin E-deficiency. Quart. Bull. Northw. Univ. med. Sch. 20, 92 (1946).
Morrell, R. M.: Abnormal hepatic tests in muscular disease. Arch. intern. Med. 104, 83 (1959).
Mosberg, G.: Beitrag zur Kenntnis des Stoffwechsels der Dystrophia musculorum progressiva. Klin. Wschr. 9, 2051 (1930).
Moser, H., U. Wiesmann, R. Richterich u. E. Rossi: Progressive Muskeldystrophie. VI. Häufigkeit, Klinik und Genetik der Duchenne-Form. Schweiz. med. Wschr. 94, 1610 (1964).
Moser, H., U. Wiesmann, R. Richterich u. E. Rossi Progressive Muskeldystrophie. VIII. Häufigkeit, Klinik und Genetik der Typen I und II. Schweiz. med. Wschr. 96, 169, 205 (1966).
Mularek, J., and M. Gembicki: The thyroid function investigation in patients with muscular atrophy using radioactive iodine 131. Psychiat. et Neurol. (Basel) 152, 156 (1966).
Murphy, E. G., and M. M. Cherniak: Glutamic oxalacetic transaminase activity in the serum in muscular dystrophy and other neuromuscular disorders in childhood. Pediatrics 22, 1110 (1958).
Myerson, R. M., J. K. Hurwitz, and T. Sall: Serum and cerebrospinal-fluid transaminase concentration in various neurologic disorders. New Engl. J. Med. 257, 273 (1957).
Nachmias, V. I., and H. A. Padykula: A histochemical investigation of normal and denervatedred and white muscles of the rat. J. biophys. biochem. Cytol. 4, 47 (1958).
Nakahara, M., and S. Yamada: Studies on progressive muscular dystrophy. IV. Effects of original amino acids mixture on progressive muscular dystrophy. Arzneimittel-Forsch. 17, 753 (1967).
Nath, K., K. M. Wahal, and V. N. Agarwal: Serum glutamic oxalacetic transaminase in muscular and neuromuscular disorders. J. Indian med. Ass. 39, 235 (1962).
Nerdrum, H. J., and K. J. Berg: Changes of serum glutamic-oxaloacetic transaminase and serum lactic dehydrogenase on physical exertion. Scand. J. clin. Lab. Invest. 16, 624 (1964).
Neustadt, J. E., R. C. Levy, and I. J. Spiegel: Carbon dioxide narcosis in association with muscular dystrophy. J. Amer. med. Ass. 187, 616 (1964).
Nevin, S.: Study of muscle chemistry in myasthenia gravis, pseudohypertrophic muscular dystrophy and myotonia. Brain 57, 239 (1934).
Nevin, S. Two cases of muscular degeneration occurring in late adult life, with a review of the recorded cases of late progressive muscular dystrophy. Quart. J. Med. 29, 51 (1936).
Nichol, C., P. L. McGeer, and J. R. Miller: Creatine kinase in normal and dystrophic mouse muscle. Canad. J. Biochem. 40, 443 (1962).
Nichol, C. J.: Creatine kinase in muscle of normal and dystrophic mice of strain 129. Canad. J. Biochem. 42, 243 (1964).
Nichol, C. J. Sulfhydryl and disulfide concentrations in dystrophic mouse muscle. Canad. J. Biochem. 42, 1643 (1964).
Nichol, C. J. Serum creatine phosphokinase in mice with muscular dystrophy. Enzym. biol. clin. 4, 217 (1964).
Nichol, C. J. Serum creatine phosphokinase measurements in muscular dystrophy studies. Clin. chim. Acta 11, 404 (1965).
Nickell, W. K., and F. F. Allbritten: Serum transaminase content related to tissue injury. Surgery 42, 240 (1957).
Niebroj-Dobosz, I., u. I. Hausmanowa-Petrusewicz: Neurol. Neurochir. pol. 13, 461 (1963).
Niebroj-Dobosz, I., u. I. Hausmanowa-Petrusewicz Pol. med. J. 3, 689 (1964).
Niebroj-Dobosz, I. Disturbances of the combustion processes in muscular disorders. J. Neurol. Neurosurg. Psychiat. 28, 19 (1965).
— Final combustion processes in muscular disorders. Proc. 8th Int. Congr. Neurology, Vienna 1965, Tom. II, p. 511.
Niebroj-Dobosz, I. and I. Hausmanowa-Petrusewicz: Biochemical disorders in muscle diseases. III. Processes of final combustion in the blood of family members of patients with progressive muscular dystrophy. Acta med. pol. 6, 125 (1965).
Nivet, M., C. Constans, and J. Facquet: Pathological elevations of creatine kinase apart from myocardial infarction. Rev. franç. Étud. clin. biol. 8, 74 (1963).
Norris, F. H., Jr., A. J. Moss, and P. N. Yu: On the possibility that a type of human muscular dystrophy commences in myocardium. Ann. N. Y. Acad. Sci. 138, 342 (1966).
Nothacker, W. G., and M. G. Netsky: Myocardial lesions in progressive muscular dystrophy. Arch. Path. 50, 578 (1950).
Ochoa, J., and W. G. Mair: The ultrastructure of normal foetal muscle and foetal muscle from known dystrophic carriers. In: Research in Muscular Dystrophy. London: Pitman 1968, p. 223.
Odom, G., C. K. Russel, and D. McEachern: Studies in neuromuscular disorders: the myogram, blood cholinesterase and effects of prostigmine in myasthenia gravis and progressive muscular dystrophy. Brain 66 I, 1 (1943).
Oepen, H., u. I. Oepen: Geschlechtsspezifische Konzentrationsunterschiede der Serum-Aminosäuren. Klin. Wschr. 43, 211 (1965).
Ogata, T.: A histochemical study of the red and white muscle fibers. I. Activity of the succinoxydase system in muscle fibers. Acta Med. Okayama 12, 216 (1958).
Ogata, T. A histochemical study of the red and white muscle fibers. II. Activity of the cytochrome oxydase system in muscle fibers. Acta Med. Okayama 12, 228 (1958).
Ogata, T. A histochemical study of the red and white muscle fibers. III. Activity of the diphos-phorydine nucleotide diaphorase and triphosphopyridine nucleotide diaphorase in muscle fibers. Acta Med. Okayama 12, 233 (1958).
Ogata, T. The differences in some labil constituents and some enzymatic activities between the red and the white muscle. J. Biochem. (Tokyo) 47, 726 (1960).
Ogata, T. and M. Mori: Histochemical demonstration of the three types of intrafusal fibers of muscle spindles. A study of oxidative enzymes. Acta Med. Okayama 16, 347 (1962).
Ogata, T. A histochemical study of hydrolytic enzymes in muscle fibers of various animals. J. Histochem. Cytochem. 11, 645 (1963).
Ogata, T. Histochemical study of oxidative enzymes in vertebrate muscles. J. Histochem. Cytochem. 12, 171 (1964).
Ohno, S., and S. Makino: The single-x nature of sex chromatin in man. Lancet 1961 I, 78.
Okinaka, S., H. Sugita, H. Momoi, Y. Toyokura, H. Kumagai, S. Ebashi, and Y. Fujie: Serum creatine phosphokinase and aldolase activity in neuromuscular disorders. Amer. Neurol. Ass. 84th Ann. Meet., Atlantic City 1959.
Okinaka, S., H. Kumagai, S. Ebashi, H. Sugita, H. Momoi, Y. Toyokura, and Y. Fujie: Serum creatine phosphokinase activity in progressive muscular dystrophy and neuromuscular diseases. Arch. Neurol. (Chic.) 4, 520 (1961).
Omar, E. M., T. M. Fergusin, C. R. Creger, and J. R. Couch: Enzyme activities in the developing muscle and liver of normal and genetically dystrophic chick embryos. Proc. Soc. exp. Biol. (N. Y.) 118, 225 (1965).
Opie, L. H., and E. A. Newsholme: The activities of fructose 1,6-diphosphatase, phosphofructokinase and phosphoenolpyruvate carboxykinase in white muscle and red muscle. Biochem. J. 103, 391 (1967).
Oppel, R. W., C. Coker, and A. T. Milhorat: The effect of pituitary adrenocorticotropin (ACTH) in dermatomyositis. Ann. intern. Med. 32, 318 (1950).
Oppenheimer, H., S. Shulman, S. Roberts, and A. T. Milhorat: Serum proteins, lipoproteins, and glycoproteins. II. Muscular dystrophy and related diseases in patients. Proc. Soc. exp. Biol. (N. Y.) 100, 564 (1959).
Oppenheimer, H., H. R. Terry, E. Forsyth, and A. T. Milhorat: Muscle proteins in mice with hereditary muscular dystrophy. Fed. Proc. 18, 460 (1959).
Oppenheimer, H. and A. T. Milhorat: Serum proteins, lipoproteins and glycoproteins in muscular dystrophy and related diseases. Ann. N. Y. Acad. Sci. 94, 308 (1961).
Oppenheimer, H., K. Barany, and A. T. Milhorat: Myosin from mice with hereditary muscular dystrophy. Proc. Soc. exp. Biol. (N. Y.) 116, 877 (1964).
Oppenheimer, H., R. B. Rogers, and A. T. Milhorat: Phosphorus in cell fractions of skeletal muscle from mice with hereditary muscular dystrophy. Proc. Soc. exp. Biol. (N. Y.) 118, 1025 (1965).
Orr, W. F., and A. S. Minot: Ribosuria, a clinical test for muscular dystrophy. Arch. Neurol. (Chic.) 67, 483 (1952).
O’Steen, K.: Growth activity of normal and dystrophic muscle implants in normal and dystrophic hosts. Lab. Invest. 11, 412 (1962).
O’Steen, K. The growth of human dystrophic skeletal muscle in diffusion chambers. Tex. Rep. Biol. Med. 21, 369 (1963).
Otto, P., E. Schmidt u. F. W. Schmidt: Enzymspiegel im Serum bei körperlicher Arbeit und ambulanten Patienten. Klin. Wschr. 42, 75 (1964).
Overzier, C., and E. P. Bleiching: Testicular atrophy in dystrophia musculorum progressiva (Erb). Lancet 1961 II, 1046.
Owens, K.: Fatty acid and aldehyde composition of normal and dystrophic muscle lipids. In: Research in Muscular Dystrophy. London: Pitman 1968, p. 363.
Pagliaro, L., and A. Notarbartolo: α-Hydroxybutyric dehydrogenase in the diagnosis of myocardial infarction. Lancet 1962 I, 1043.
Pallikan, D.: Studien über den Kohlehydratstoffwechsel bei Dystrophia musculorum progressiva. Z. Neurol. 166, 236 (1939).
Palmieri, A., e S. Giacca: Comportamento delle curve da carico di ferro per os e per via endovenosa in un caso di atrofia muscolare progressiva. Arch. E. Maragliano Pat. Clin. 13, 1159 (1957).
Pansini, R., e N. Sozio: Ricerche sulla fisiopatologia muscolare dell’uomo; comportamento dell’alcoolemia, piruvicemia e glicemia nel circolo venoso superficiale dopo carico d’insulina in miopatici. Rass. Fisiopat. clin. ter. 25, 421 (1953).
Park, D. C., and R. J. Pennington: Intracellular distribution of some enzymes in normal skeletal muscle. Clin. chim. Acta 13, 694 (1966).
Patterson, M., and G. Rios: Disturbed gastrointestinal motility. Unusual manifestation of systemic muscular disorder; polymyositis or progressive muscular dystrophy. Gastroenterology 36, 261 (1959).
Patterson, M., and G. Rios Gastrointestinal tract and muscular dystrophy. Tex. Rep. Biol. Med. 17, 502 (1959).
Patterson, M., H. Ong, and A. Drake: Intestinal absorption in muscular dystrophy patients. Arch. intern. Med. 114, 67 (1964).
Pawlak, M., et R. Pion: Influence de la composition des protéines alimentaires sur les teneurs en acides amines libres du sang total et du muscle du rat en croissance. C. R. Acad. Sci. (Paris) 264, 380 (1967).
Pearce, G. W.: Electron microscopy in the study of muscular dystrophy. In: Muscular Dystrophy in Man and Animals. Edit. by G. H. Bourne and M. N. Golarz. New York: S. Karger 1963.
Pearce, G. W. Tissue culture and electron microscopy. In: Research in Muscular Dystrophy. London: Pitman 1963, p. 75.
Pearce, G. W. Tissue culture and electron microscopy in muscle disease. In: Disorders of Voluntary Muscle. Edit. by J. N. Walton. London: J. A. Churchill 1964.
Pearce, G. W., J. M. S. Pearce, and J. N. Walton: The Duchenne type muscular dystrophy. Histopathological studies of the carrier state. Brain 89, 109 (1966).
Pearce, G. W. Electron microscopy in the study of muscular dystrophy. Ann. N. Y. Acad. Sci. 138, 138 (1966).
Pearce, J. M., R. J. Pennington, and J. N. Walton: Serum enzyme studies in muscle disease. II. Serum creatine kinase activity in muscular dystrophy and in other myopathic and neuropathic disorders. J. Neurol. Neurosurg. Psychiat. 27, 96 (1964).
Pearce, J. M., R. J. Pennington, and J. N. Walton Serum enzyme studies in muscle disease. III. Serum creatine kinase activity in relatives of patients with the Duchenne type of muscular dystrophy. J. Neurol. Neurosurg. Psychiat. 27, 181 (1964).
Pearse, A. G. E.: Direct relationship of phosphorylase and mitochondrial α-glycero-phosphate dehydrogenase activity in skeletal muscle. Nature (Lond.) 191, 504 (1961).
Pearse, A. G. E. The histoenzymology of normal and diseased muscle. In: Research in Muscular Dystrophy. London: Pitman 1963, p. 189.
Pearson, C. M.: Serum enzymes in muscular dystrophy and certain other muscular and neuromuscular diseases. New Engl. J. Med. 256, 1069 (1957).
Pearson, C. M., W. S. Beck, and W. H. Blahd: Idiopathic paroxysmal myoglobinuria. Arch. intern. Med. 99, 376 (1957).
Pearson, C. M. Biochemical and histochemical research. Lancet 1961 I, 276.
Pearson, C. M., S. R. Chowdhury, and W. M. Fowler: Biochemical detection and histological study of muscular dystrophy in the preclinical stage. J. clin. Invest. 40, 1070 (1961).
Pearson, C. M., W. M. Fowler Jr., M. H. Jones, and W. H. Griffith: Studies of enzymes in serum in muscular dystrophy. II. Diagnostic and prognostic significance in relatives of dystrophic persons. Pediatrics 28, 962 (1961).
Pearson, C. M. Polymyositis: clinical forms, diagnosis and therapy. Postgrad. Med. 31, 450 (1962).
Pearson, C. M. Biochemical and histological features of early muscular dystrophy. Rev. canad. Biol. 21, 533 (1962).
Pearson, C. M. Histopathological features of muscle in the preclinical stages of muscular dystrophy. Brain 85, 109 (1962).
Pearson, C. M. Muscular dystrophy. Review and recent observations. Amer. J. Med. 35, 732 (1963).
Pearson, C. M., W. M. Fowler, and S. W. Wright: X-chromosome mosaicism in females with muscular dystrophy. Proc. nat. Acad. Sci. (Wash.) 50, 24 (1963).
Pearson, C. M., N. C. Kar, J. B. Peter, and T. L. Munsat: Muscle lactate dehydrogenase patterns in two types of X-linked muscular dystrophy. Amer. J. Med. 39, 91 (1965).
Pearson, C. M. Isoenzymes: general considerations and alterations in human and animal myopathies. Ann. N. Y. Acad. Sci. 138, 293 (1966).
Pellegrino, C., and C. Bibbiani: Increase of muscle permeability to aldolase in several experimental atrophies. Nature (Lond.) 204, 483 (1964).
Pellet, H.: Pathologie musculaire. Apport de l’expérimentation. Presse méd. 74, 165 (1966).
Pennington, R. J., and P. Leyburn: Glucose utilization by erythrocytes from muscular dystrophy patients. Clin. chim. Acta 5, 766 (1960).
Pennington, R. J. 5′-adenylic acid deaminase in dystrophic mouse muscle. Nature (Lond.) 192, 884 (1961).
Pennington, R. J. Biochemistry of dystrophic muscle. Mitochondrial succinate-tetrazolium reductase and adenosine triphosphatase. Biochem. J. 80, 649 (1961).
Pennington, R. J. Some enzyme studies in muscular dystrophy. Proc. Ass. clin. Biochem. 2, 17 (1962).
Pennington, R. J. Muscle enzymes in animal and human dystrophy. In: Research in Muscular Dystrophy. London: Pitman 1963, p. 159.
Pennington, R. J. Biochemical aspects of muscle disease. In: Disorders of Voluntary Muscle. Edit. by J. N. Walton. London: J. A. Churchill 1964.
Pennington, R. J., D. C. Park, and C. P. Freeman: The fatty acid composition of infiltration fat in muscle from a case of muscular dystrophy. Clin. chim. Acta 13, 399 (1966).
Perkoff, G. T., and F. H. Tyler: Studies in disorders of muscle. XI. The problem of pentosuria in progressive muscular dystrophy. Metabolism 5, 563 (1956).
Perkoff, G. T., D. M. Brown, and F. H. Tyler: The isolation of myoglobin in progressive muscular dystrophy. J. clin. Endocr. 17, 1489 (1957).
Perkoff, G. T. and F. H. Tyler: Creatine metabolism in the Bar Habor 129 strain dystrophic mouse. Metabolism 7, 745 (1958).
Perkoff, G. T. R. L. Hill, and F. H. Tyler: Abnormal myoglobin chromatography in childhood muscular dystrophy. J. clin. Invest. 41, 1391 (1962).
Perkoff, G. T. Studies of myoglobin in idiopathic myoglobinuria. Clin. Res. 11, 115 (1963).
Perkoff, G. T. Studies of human myoglobin in several diseases of muscle. New Engl. J. Med. 270, 263 (1964).
Perkoff, G. T. Evidence for a specific human fetal muscle heme protein. J. Lab. clin. Med. 67, 585 (1966).
Perloff, J. K., W. C. Roberts, A. C. De Leon, and D. O’Doherty: The distinctive electrocardiogram of Duchenne’s progressive muscular dystrophy. An electrocardio-graphic-pathologic correlative study. Amer. J. Med. 42, 179 (1967).
Peterson, D. W., A. L. Lilyblade, and J. Lyon: Serine-ethanolamine-phosphate, taurine, and free amino acids of muscles in hereditary muscular dystrophy of the chicken. Proc. Soc. exp. Biol. (N. Y.) 118, 798 (1963).
Pette, D., M. Klingenberg, and T. Buecher: Comparable and specific proportions in the mitochondrial enzyme activity pattern. Biochem. biophys. Res. Commun. 7, 425 (1962).
Pette, D. u. T. Buecher: Proportionskonstante Gruppen in Beziehung zu Differenzierung der Enzymaktivitätsmuster von Skelett-Muskeln des Kaninchens. Hoppe-Seylers Z. physiol. Chem. 331, 180 (1963).
Pilsum, J. F. Van, and R. E. Wahman: Creatine and creatinine in the carcass and urine of normal and vitamin E-deficient rabbits. J. biol. Chem. 235, 2092 (1960).
Pirelli, A.: Particolari caratteristiche metaboliche del plasma di soggetti affetti da distrofia muscolare progressiva. L’effetto plasmatico sulla utilizzazione del glucosio da parte del diaframma di ratto. Boll. Soc. ital. Biol. sper. 40, 935 (1964).
Plagemann, P. G. W., K. F. Gregory, and F. Wroblewski: The electrophoretically distinct forms of mammalian lactic dehydrogenase. II. J. biol. Chem. 235, 2282 (1960).
Plauchu, G., P. Galy, A. Perrin, J. M. Robert et J. Délaye: Insuffisance ventilatoire et hypertension artérielle pulmonaire au cours d’une dystrophie musculaire progressive familiale. Le problème du cœur pulmonaire chronique dans les myopathies. Cœur Méd. inter. 5, 281 (1966).
Poortmans, J., J. J. S’jongers, A. Thys, and E. Van Kerchhove: The transaminase activity of the whole blood and serum during muscular effort. Rev. franç. Étud. clin. biol. 8, 173 (1963).
Pope, R. S., E. D. Murphy, and W. T. West: Histopathology of dystrophic and normal mice after timed periods of parabiosis. Anat. Rec. 151, 151 (1965).
Popoviciu, L., M. Pirvu, T. Lazar, I. Proinov, O. Pavel, R. Catana et S. Comes: Recherches biochimiques dans certaines maladies hérédodégénératives du système nerveux. Arch. Un. méd. balkan. 2, 181 (1964).
Pruzanski, W., and A. G. Huvos: Smooth muscle involvement in primary muscle disease. L Myotonic dystrophy. Arch. Path. 83, 229 (1967).
Prystowsky, H., A. E. Hellegers, E. Ranke, B. Ranke, and B. F. Chow: Further observations on the metabolism of vitamin B12 in human pregnancy. Amer. J. Obstet. Gynec. 77, 1 (1959).
Rabinowitz, J. L.: Studies on dystrophic mice and their litter mates. Fed. Proc. 18, 306 (1959).
Rabinowitz, J. L., J. Burns, G. D. Chase, and H. C. Allen: Studies on dystrophic mice and their littermates. I. Blood volume determinations. Atompraxis 5, 487 (1959).
Rabinowitz, J. L. Enzymic studies on dystrophic mice and their littermates (lipogenesis and cholesterol-genesis). Biochim. biophys. Acta 43, 337 (1960).
Radu, H., I. Gödri, G. Blücher, S. Migea, L. Bordeianu et I. Lupsa: L’étude du métabolisme du P32 et du K42 dans la dystrophie musculaire progressive. Proc. 8th Int. Congr. Neurology, Vienna 1965, Tom. II, p. 519.
Radu, H., I. Gödri, G. Blücher, S. Migea, L. Bordeianu et I. Lupsa 32P-Stoffwechselstudie bei Muskelkrankheiten verschiedener Genese. In: Progressive Muskeldystrophie, Myotonie, Myasthenie. Hrsg. von E. Kühn. Berlin-Heidelberg-New York: Springer 1966, S. 139.
Ranvier, M. L.: Propriétés et structures différentes des muscles rouges et des muscles blancs, chez les lapins et chez les rats. C. R. Acad. Sci. (Paris) 77, 1030 (1873).
Read, W. O., and S. Nehorayan: Effect of vitamin E-deficiency on creatine phosphokinase of heart and skeletal muscle. Amer. J. Physiol. 196, 1286 (1959).
Read, W. O. Creatine phosphokinase in muscles of dystrophic mice. Proc. Soc. exp. Biol. (N. Y.) 109, 696 (1962).
Rehn, J., E. Köhnlein, S. Graner u. A. Zeller: Über den Einfluß chirurgischer Eingriffe auf die Fermentaktivität im Serum. Med. Welt (Stuttg). 1960, 347.
Reinhold, J. G., and G. R. Kingsley: The chemical composition of voluntary muscle in muscle disease: A comparison of progressive muscular dystrophy with other diseases together with a study of effects of glycine and creatine therapy. J. clin. Invest. 17, 377 (1938).
Richter, K., u. K. Konitzer: Veränderungen der Aldolaseaktivität im Blutserum bei Muskelarbeit. Klin. Wschr. 38, 998 (1960).
Richterich, R.: Enzympathologie. Enzyme in Klinik und Forschung. Berlin-Heidelberg-New York: Springer 1958.
Richterich, R., E. Gautier, W. Egli, K. Zuppinger u. E. Rossi: Progressive Muskeldystrophie. I. Die Heterogenität der Serum-Lactat-Dehydrogenase. Klin. Wschr. 39, 346 (1961).
Richterich, R., S. Rosin, u. Aebi, and E. Rossi: Progressive muscular dystrophy. V. The identification of the carrier state in the Duchenne type by serum creatine kinase determination. Amer. J. hum. Genet. 15, 133 (1964).
Richterich, R. Zur Biochemie der progressiven Muskeldystrophie. In: Myopathien. Hrsg. von R. Beckmann. Stuttgart: G. Thieme 1965, S. 187.
Richterich, R. Biochemische Unterschiede zwischen Muskel-Dystrophie und Muskel-Atrophie. Cytoplasmatische Enzyme in der Muskulatur. In: Progressive Muskeldystrophie, Myotonie, Myasthenie. Hrsg. von E. Kuhn. Berlin-Heidelberg-New York: Springer 1966, S. 155.
Riesser, O.: Beiträge zur Physiologie des Kreatins. Hoppe-Seylers Z. physiol. Chem. 120, 189 (1922).
Ritter, J., and D. Seligson: Elevation of serum glutamic oxalacetic transaminase and urinary coproporphyrins in pseudohypertrophic muscular dystrophy. Amer. J. med. Sci. 233, 559 (1957).
Robin, G. C., and G. Falewski: Acute gastric dilatation in progressive muscular dystrophy. Lancet 1963 I, 171.
Roderuck, C. E., D. H. Basinski, and M. A. Barber: Some chemical and enzymic alteration in muscle in experimental dystrophy. Ann. N. Y. Acad. Sci. 52, 156 (1949).
Roderuck, C. E. Analysis of certain components of skeletal muscle during vitamin E-deficiency. J. biol. Chem. 181, 11 (1949).
Roffler, S. A., P. H. Weswig, O. H. Muth, and J. E. Oldsfield: 5′-nucleotidase activity in chickens, cotton rats, and lambs with nutritional myopathies. Proc. Soc. exp. Biol. (N. Y.) 121, 780 (1966).
Romanul, F. C. A.: Enzymes in muscle. I. Histochemical studies of enzymes in individual muscle fibers. Arch. Neurol. (Chic.) 11, 355 (1964).
Romanul, F. C. A. Distribution of capillaries in relation to oxidative metabolism of skeletal muscle fibres. Nature (Lond.) 201, 307 (1964).
Romanul, F. C. A. Capillary supply and metabolism of muscle fibers. Arch. Neurol. (Chic.) 12, 497 (1965).
Ronzoni E., S. M. Wald, R. L. Lam, and E. F. Fildea: Ribosuria in muscular dystrophy. Neurology (Minneap.) 5, 412 (1955).
Ronzoni E., S. M. Wald, L. Berg, and R. Ramsey: Distribution of high energy phosphate in normal and dystrophic muscle. Neurology (Minneap.) 8, 359 (1958).
Ronzoni E., L. Berg, and W. Landau: Enzyme studies in progressive muscular dystrophy. In: Neuromuscular Disorders. Res. Publ. Ass. nerv. ment. Dis. 38, 721 (1961).
Rosa, J., R. Saddi et G. Schapira: Migration électrophorétique de la transaminase sérique glutamique-oxaloacétique chez le sujet normal et le myopathe. C. R. Soc. Biol. (Paris) 152 (1958) 152.
Rosalki, S. B.: Creatine phosphokinase isoenzymes. Nature (Lond.) 207, 414 (1965).
Rosalki, S. B. Fibre composition of skeletal muscle. Persönl. Mitteilung vom 4. 1. 1966 (St. Mary’s Hospital, London W. 2).
Rosalki, S. B. An improved procedure for serum creatine phosphokinase determination. J. Lab. clin. Med. 69, 696 (1967).
Rosalki, S. B. Creatine kinase and brain damage. Lancet 1967 II, 722.
Rosalki, S. B. Lactic dehydrogenase activity and isoenzymes of human skeletal muscle. In: Research in Muscular Dystrophy. London: Pitman 1968, p. 348.
Rose, C. S., and P. György: Specificity of hemolytic reaction in vitamin E-deficient erythrocytes. Amer. J. Physiol. 168, 414 (1952).
Rosenkrantz, H., A. T. Milhorat, and M. Färber: Intestinal absorption of vitamin E preparations in patients with muscular dystrophy. Metabolism 2, 556 (1953).
Rosenkrantz, H. Studies in vitamin E-deficiency. I. The oxygen consumption of various tissues from the rabbit. J. biol. Chem. 214, 789 (1955).
Rosenkrantz, H. Studies in vitamin E-deficiency. IV. The influence of steroid hormones on rabbit skeletal muscle. J. biol. Chem. 234, 35 (1959).
Rosenkrantz, H. Dehydrogenase levels in mice with muscular dystrophy. Fed. Proc. 18, 312 (1959).
Rosenkrantz, H. and R. O. Laferte: A comparison of reducing systems in vitamin E-deprived rabbits and mice with dystrophia muscularis. Arch. Biochem. 89, 173 (1960).
Rosenthal, M.: Handbuch der Diagnostik und Therapie der Nervenkrankheiten. Erlangen: F. Enke 1870, S. 220.
Ross, J.: On a case of pseudohypertrophic paralysis. Brit. med. J. 1, 200 (1883).
Ross, K. F. A., and D. E. Jans: The nuclear and cytoplasmic RNA in normally differentiating and dystrophic myoblasts. In: Research in Muscular Dystrophy. London: Pitman 1968, p. 240.
Rossi, F., M. Zatti A. Tartarini: Ricerche su alcune vie di riossidazione del TPNH in condizioni di maggiore attivita della G-6-P deidrogenasi e 6-PG deidrogenasi nel muscolo. Sperimentale 113, 15 (1963).
Rotthauwe, H. W., u. S. Koalewski: Klinische und biochemische Untersuchungen bei Myopathien. I. Serumenzyme bei progressiver Muskeldystrophie (Typ I, II, III a). Klin. Wschr 43, 144 (1965).
Rotthauwe, H. W., u. S. Koalewski: Klinische und biochemische Untersuchungen bei Myopathien. II. Die Bedeutung der Serum-Kreatin-Phosphokinase und der Serum-Aldolase für die Identifizierung von Heterozygoten der recessiv x-chromosomalen Formen der progressiven Muskeldystrophie (Typ 3a und b). Klin. Wschr. 43, 150 (1965).
Rotthauwe, H. W., u. S. Koalewski: Gutartige recessiv x-chromosomal vererbte Muskeldystrophie. I. Untersuchungen bei Merkmalträgern. Hum. Genet. 3, 17 (1966).
Rotthauwe, H. W., u. S. Koalewski: Aktivierung und Alterung der Serum-Kreatin-Phosphokinase. Klin. Wschr. 45, 387 (1967).
Rotthauwe, H. W., u. S. Koalewski: Bestimmung der aktivierten Serum-Kreatin-Phosphokinase. Z. klin. Chem. 5, 254 (1967).
Rowland, L. P.: Diskussionsbemerkung zum Vortrag “Tissue and serum aldolase in neuromuscular disease” von S. B. Aronson u. B. W. Volk. Arch. Neurol. (Chic.) 75, 568 (1956).
Rowland, L. P. and G. Ross: Serum aldolase in muscular dystrophies, neuromuscular disorders and wasting of skeletal muscle. Arch. Neurol. (Chic.) 80, 157 (1958).
Rowland, L. P. Muscular dystrophies and related diseases: metabolic aspects. Manitoba med. Rev. 44, 540 (1964).
Rubin, I. L., and A. S. Buchberg: The heart in progressive muscular dystrophy. Amer. Heart J. 43, 161 (1952).
Rubinstein, L. J.: Triphosphopyridine nucleotide (TPN) diaphorase and TPN-dependent dehydrogenase activity of reactive macrophages in tissue necrosis. Nature (Lond.) 193, 895 (1962).
Rulon, R. R., D. D. Schottelius, and B. A. Schottelius: Phosphorylase activation in stimulated dystrophic mouse muscle. Amer. J. Physiol. 202, 821 (1962).
Salvi, G., u. Ambanelli, G. Rosati, M. Carreras, and F. Mironi: Changes in serum glutamic oxalacetic transaminases and aldolases in muscle diseases, with special reference to Steinert’s myotonic dystrophy. Riv. Pat. nerv. ment. 80, 1 (1959).
Sandberg, A. A., H. H. Hecht, and F. H. Tyler: The heart in muscular dystrophy. Amer. J. Med. 13, 498 (1952).
Sandberg, A. A., H. H. Hecht, and F. H. Tyler: Studies in disorders of muscle. X. The site of creatine synthesis in the human. Metabolism 2, 22 (1953).
Sarkar, N. K., and U. Srivastava: Biochemical changes in progressive muscular dystrophy. II. Phosphorus metabolism in normal, nutritional, and hereditary dystrophic muscles, livers and brains of animals. J. Nutr. 83, 193 (1964).
Sarteschi, P., e P. Fabiana: Boll. Soc. med.-chir. 26, 187 (1958).
Scott, M. L., and C. C. Calvert: Evidence of a specific effect of cystine in the prevention of nutritional muscular dystrophy in vitamin E-deficient chicks. J. Nutr. 77, 105 (1962).
Scott, M. L., E. Søndergaard, and H. Dam: A lack of relationship between succinic dehydrogenase and nutritional muscular dystrophy in chicks. Fed. Proc. 21, 473 (1962).
Seidel, J. C., F. A. Sreter, M. M. Thompson, and J. Gergely: Comparative studies of myofibrils, myosin, and actomyosin from red and white rabbit skeletal muscle. Biochem. biophys. Res. Commun. 17, 662 (1964).
Severin, S. E., I. M. Bocharnikova, P. L. Vulfson, X. A. Grigorovich u. G. A. Soloveva: Die biologische Bedeutung des Carnosin. (Russ.) Biokhimiya 28, 510 (1963).
Shabanova, I. A.: Carbohydrate-phosphorus metabolism in the muscles of rats in experimental muscular dystrophy. Biokhimiya 18, 385 (1953). Ref.: Chem. Abstr. 48, Nr. 4681 (1954).
Shank, R. E., H. Gilder, and C. L. Hoagland: Studies on diseases of muscle. I. Progressive muscular dystrophy; a clinical review of 40 cases. Arch. Neurol. (Chic.) 52, 431 (1944).
Shapiro, H. S., J. Ribeilima, and V. E. Wendt: Myocardial infarction in progressive muscular dystrophy. Amer. J. Cardiol. 14, 232 (1964).
Sharma, N. L., K. M. Goel, P. N. Mehrotra, and J. S. Anand: Glutamic oxalacetic transaminase (GOT) activity in serum and cerebrospinal fluid in muscular dystrophy. Indian J. Pediat. 31, 145 (1964).
Sharma, N. L., A. Kumar, K. M. Goel, and A. K. Rastogi: Glutamic oxalacetic transaminase (GOT) activity in serum and cerebrospinal fluid in muscular dystrophy. Indian J. med. Res. 53, 334 (1965).
Shaw, R. F., C. M. Pearson, and S. R. Chowdhury: Statistical characteristics and normal values of four serum enzymes, glutamic oxalacetic transaminase, glutamic pyruvic transaminase, aldolase, and creatine phosphokinase. Enzym. biol. clin. 6, 10 (1966).
Shaw, R. F., C. M. Pearson, and S. R. Chowdhury and F. E. Dreifuss: Serum enzymes in sex-linked (Duchenne) muscular dystrophy. Arch. Neurol. (Chic.) 16, 115 (1967).
Shepard, T. H., L. H. Gordon, and J. E. Wollenweber: Lactic dehydrogenase isoenzymes in muscle from patients with Duchenne muscular dystrophy. Nature (Lond.) 208, 1107 (1965).
Shinozaki, T.: J. Okayama med. Ass. 74, 487 (1962).
Shonk, C. E., B. J. Koven, H. Majima, and G. E. Boxer: Enzyme patterns in human tissues. II. Glycolytic enzyme patterns in nonmalignant human tissues. Cancer Res. 24, 722 (1964).
Shull, R. L., and R. B. Alfin-Slater: Tissue lipids of dystrophia muscularis, a mouse with inherited muscular dystrophy. Proc. Soc. exp. Biol. (N. Y.) 97, 403 (1958).
Shy, G. M., D. J. Cummings, L. Berg, and B. Horvath: Muscular dystrophy. Potassium exchange in residual muscle. J. appl. Physiol. 8, 33 (1955).
Siblet, J. A., and A. L. Lehninger: Determination of aldolase in animal tissues. J. biol. Chem. 177, 859 (1949).
Siblet, J. A., and A. L. Lehninger Aldolase in the serum and tissues of tumor-bearing animals. J. nat. Cancer Inst. 9, 303 (1949).
Sibrik, I. De, and D. S. O’Doherty: Oxidative enzymes in muscular dystrophy. Neurology (Minneap.) 13, 554 (1963).
Siedler, A. J., W. P. Norman, and R. N. Sayre: Muscular dystrophy. A problem in polyunsaturated fatty acid metabolism? Amer. J. clin. Nutr. 15, 187 (1964).
Siekert, R. G., and G. A. Fleisher: Serum GOT in certain neurologic and neuromuscular diseases. Mayo Clin. Proc. 31, 459 (1956).
Simon, E. J., I. M. Lessell, C. S. Gross, and A. T. Milhorat: Amino acid incorporation into muscle and liver proteins of mice with hereditary muscular dystrophy. Fed. Proc. 17, 311 (1958).
Simon, E. J., C. S. Gross, and I. M. Lessell: Turnover of muscle and liver proteins in mice with hereditary muscular dystrophy. Arch. Biochem. 96, 41 (1962).
Singer, K., B. Angelopoulos, and G. Ramot: Studies on human myoglobin. II. Fetal myoglobin; its identification and its replacement by adult myoglobin during infancy. Blood 10, 987 (1955).
Singh, S. D., R. Vijayvergiya, E. S. Ranawat, and D. E. Antia: Myopathy (Progressive muscular dystrophy). A clinical and tissue respiration study. Indian J. Pediat. 29, 397 (1962).
Singh, S. D. and I. K. Somani: Indian Practit. 16, 433 (1963).
Sitzmann, F. C.: Untersuchungen über das Verhalten der Creatinphosphokinase während der Neugeborenenperiode. Z. Kinderheilk. 96, 343 (1966).
Sitzmann, F. C. Kreatinphosphokinase-Aktivität im Serum bei Säuglingen und Kleinkindern. Z. Kinderheilk. 99, 48 (1967).
Sjaastad, O.: Urinary excretion of histamine in patients with various muscular disorders. Acta med. scand. 179, 269 (1966).
Sjövall, K., and A. Voigt: Creatine-phospho-transferase isoenzymes. Nature (Lond.) 202, 701 (1964).
Skyring, A., and V. A. McKusick: Clinical, genetic and electrocardiographic studies in childhood muscular dystrophy. Amer. J. med. Sci. 242, 534 (1961).
Smith, D. M., R. M. Paul, E. G. McGeer, and P. L. McGeer: A general chromatographic survey of aromatic compounds obtained from urine. Canad. J. Biochem. 37, 1493 (1959).
Smith, E. L., G. E. Cartwright, F. H. Tyler, and M. M. Wintrobe: On the origin of certain serum peptidases as indicated by experimental hemolytic anemia in dogs. J. biol. Chem. 185, 59 (1950).
Smith, H. L., R. L. Ftscher, and J. N. Etteldorf: Magnesium and calcium in human muscular dystrophy. Amer. J. Dis. Child. 103, 771 (1962).
Smith, H. L., L. D. Amick, and W. W. Johnson: Detection of subclinical and carrier states in Duchenne muscular dystrophy. J. Pediat. 69, 67 (1966).
Smith, J. C., V. M. Foldes, and F. F. Foldes: Distribution of cholinesterase in normal human muscle. Canad. J. Biochem. 41, 1713 (1963).
Smith, L. C., and S. R. Nelson: Effect of vitamin E-deficiency on free amino acids of various rabbit tissues. Proc. Soc. exp. Biol. (N. Y.) 94, 644 (1967).
Smith, R. D., and R. P. Giovacchini: The vascularity of some red and white muscles of the rabbit. Acta anat. (Basel) 28, 342 (1956).
Smoller, M., and R. A. Fineberg: Studies of myosin in hereditary muscular dystrophy in mice. J. clin. Invest. 44, 615 (1965).
Soffer, L. J., A. Sito, L. L. Shane, and J. L. Gabrilove: The urinary excretion of the neutral 17-ketosteroids in myotonic dystrophy. J. Mt Sinai Hosp. 30, 285 (1963).
Soltan, A. C., and M. Blanchaer: Activity of aldolase and lactic dehydrogenase in patients affected with Duchenne muscular dystrophy, and in their immediate relatives. J. Pediat. 54, 27 (1959).
Spencer, H. C., S. Morgulis, and V. M. Wilder: A micromethod for the determination of gelatin and a study of the collagen content of muscles from normal and dystrophic rabbits. J. biol. Chem. 120, 257 (1937).
Sreter, F. A., and J. Gergely: Comparative studies of the Mg activated ATPase activity and Ca uptake of fractions of white and red muscle homogenates. Biochem. biophys. Res. Commun. 16, 438 (1964).
Sreter, F. A. Comparative studies on white and red muscle fractions. Fed. Proc. 23, 930 (1964).
Srivastava, U., A. Devi, and N. Sarkar: Biochemical changes in progressive muscular dystrophy. I. Xucleic acid metabolism in normal and dystrophic rabbit and mouse liver, brain and muscle. Exp. Cell Res. 29, 289 (1963).
Srivastava, U. and L. Berlinguet: Aldolase activity in normal and dystrophic mouse muscle. Canad. J. Biochem. 42, 1301 (1964).
Srivastava, U. and L. Berlinguet Biochemical changes in progressive muscular dystrophy. V. Incorporation of leucine-C 14 into protein of various tissues of normal and dystrophic mice. Arch. Biochem. 114, 320 (1966).
Srivastava, U. and L. Berlinguet Cholinesterase and monoamine oxidase activities in skeletal muscle of normal and hereditary dystrophic mice. Canad. J. Biochem. 45, 573 (1967).
Srivastava, U. Biochemical changes in progressive muscular dystrophy. Canad. J. Biochem. 45, 1419 (1967).
Sugita, H., and F. H. Tyler: Pathogenesis of muscular dystrophy. Trans. Ass. Amer. Phycns 76, 231 (1963).
Sundermeyer, J. F., S. Gudbjarnason, V. E. Wendt, P. B. Den Barker, and R. J. Bing: Myocardial metabolism in progressive muscular dystrophy. Circulation 24, 1348 (1961).
Susheela, A. K.: Structural and enzymatic changes in muscle due to aging. Nature (Lond.) 204, 296 (1964).
Svilokos, N., L. Serafini e G. Verdura: La glicociaminuria in bambini normali e miodistrofici. Minerva pediat. 10, 549 (1958).
Swaiman, K. F., and B. Sandler: The use of serum creatine phosphokinase and other serum enzymes in the diagnosis of progressive muscular dystrophy. J. Pediat. 63, 1116 (1963).
Swaiman, K. F. and E. A. Awad: Creatine phosphokinase and other serum enzyme activity after controlled exercise. Neurology (Minneap.) 14, 977 (1964).
Swaiman, K. F. Chemical laboratory studies in muscular disease. Postgrad. Med. 41, 144 (1967).
Schaffer, P. A.: The excretion of creatinin and creatin in health and disease. Amer. J. Physiol. 23, 1 (1908).
Schapira, G., et J. C. Dreyfus: Recherches sur la biochimie du fer musculaire. VI. Nature des «fers non héminiques » musculaires. Bull. Soc. Chim. biol. (Paris) 133, 265 (1951).
Schapira, G., et J. C. Dreyfus et F. Schapira: L’élévation du taux de l’aldolase sérique, test biochimique des myopathies. Sem. Hôp. Paris 29, 1917 (1953).
Schapira, G., M. Joly et J. C. Dreyfus: Longueur des particules de myosine humaine de muscle normal et myopathique déterminée par biréfringence d’écoulement. C. R. Soc. Biol. (Paris) 148, 1056 (1954).
Schapira, G., J. C.Dreyfus, F.Schapira, and J.Kruh: Glycogenic enzymes in human progressive muscular dystrophy. Proc. 3rd Med. Conf. Musc. Dystr. Ass. America, New York 1954, p. 313.
Schapira, G. Glycogenolytic enzymes in human progressive muscular dystrophy. Amer. J. phys. Med. 34, 313 (1955).
Schapira, G. Données biochimiques récentes sur les maladies primitives du muscle. Expos. ann. Biochim. méd. 17, 251 (1955).
Schapira, G. Lacticodéhydrase plasmatique au cours des myopathies. C. R. Soc. Biol. (Paris) 151, 22 (1957).
Schapira, F., J. Demos, G. Schapira et J. C. Dreyfus: Facteurs de l’hyperaldolasémie au cours des myopathies. Rev. franç. Étud. clin. biol. 2, 728 (1957).
Schapira, F., G. Schapira et J. C. Dreyfus: Hyperaldolasémie chez la souris myopathique. C. R. Acad. Sci. (Paris) 245, 754 (1957).
Schapira, F., J. C. Dreyfus et G. Schapira: Présence de deux aldolases de type différent dans le sérum. C. R. Acad. Sci. (Paris) 245, 808 (1957).
Schapira, F. et J. Demos: Étude de l’aldolase et de la créatine-kinase du sérum chez les mères de myopathes. Rev. franç. Étud. clin. biol. 5, 990 (1960).
Schapira, G., et F. Schapira: Les aldolases du sérum. Ann. Biol. clin. 18, 1 (1960).
Schapira, G. J. Frézal, J. Demos et J. C. Dreyfus: Circulation time in the relatives and siblings of myopathic patients. Statistical and genetic study. Rev. franç. Étud. clin. biol. 7, 485 (1962).
Schapira, F., J. Demos et Y. Forthoffer: La lacticodèshydrogénase sérique des mères de myopathes. Enzym. biol. clin. 2, 45 (1962).
Schapira, G., and J. C. Dreyfus: Biochemistry of progressive muscular dystrophy. In: Muscular Dystrophy in Man and Animals. Edit. by G. H. Bourne and M. N. Golarz. New York: Hafner 1963, p. 47.
Schapira, F., J. C. Dreyfus et C. Lauer: La crèatine-kinase du sérum chez la souris myopathique. Enzym. biol. clin. 3, 53 (1963).
Schapira, F. Modification des isozymes de la lacticodèshydrogénase musculaire au cours de l’atrophie expérimentale. Enzym. biol. clin. 4, 23 (1964).
Schapira, G., et J. C. Dreyfus: Enzymes au cours des maladies du muscle strié. Ann. Biol. clin. 22, 655 (1964).
Schapira, F., et R. Debré: Modification des isozymes de la créatine-kinase musculaire au cours de l’atrophie. C. R. Acad. Sci. (Paris) 262, 2291 (1966).
Schapira, G., F. Schapira et J. C. Dreyfus: Biochimie du muscle strié au cours des maladies musculaires humaines. Z. klin. Chem. 5, 241 (1967).
Schettini, E.: Ann. ital. Pediat. 16, 317 (1963).
Schittenhelm, A., u. F. Bühler: Die Beeinflußbarkeit der Spontankreatinurie bei innersekretorischen Störungen, ihr Vorkommen und ihr diagnostischer Wert. Z. ges. exp. Med. 95, 197 (1935).
Schlang, H. A.: The effect of physical exercise on serum transaminase. Amer. J. med. Sci. 242, 338 (1961).
Schliephake, E.: Der kardio-intestinale Symptomenkomplex bei der progressiven Muskeldystrophie. II. Graphische Untersuchungen. Z. Kinderheilk. 47, 85 (1929).
Schmalbruch, H.: Fasertypen der menschlichen Muskulatur. Klin. Wschr. 45, 755 (1967).
Schmidt, C. G., u. H. Schlief: Untersuchungen über das Cytochrom-und Succin-oxydasesystem des Skeletmuskels bei neurogener Atrophie. Z. ges. exp. Med. 127, 53 (1956).
Schmidt, E., F. W. Schmidt, H. D. Horn u. U. Gerlach: Die Bedeutung der Messung von Enzym-Aktivitäten in der Medizin. In: Methoden der enzymatischen Analyse. Hrsg. von H. U. Bergmeyer. Weinheim: Verlag Chemie 1962.
Schmidt, E., F. W. Schmidt, H. D. Horn u. U. Gerlach Release of enzymes from the liver. Nature (Lond.) 213, 1125 (1967).
Schneck, L., J. Maisel, and B. W. Volk: The startle response and serum enzyme profile in early detection of Tay-Sachs’ disease. J. Pediat. 65, 749 (1964).
Schneider, K. W., u. E. R. Heise: Die diagnostische Bedeutung einer erhöhten Kreatin-Phosphokinase-Aktivität im Serum. Dtsch. med. Wschr. 88, 520 (1963).
Schneiderman, L. J.: Myoglobin in the human fetus. Nature (Lond.) 194, 191 (1962).
Schneiderman, L. J. and W. I. Sampson: Blood anomaly points to muscular dystrophy. J. Amer. med. Ass. 197, 43 (1966).
Schönenberg, H.: Papierchromatographische Untersuchungen bei der Dystrophia musculorum progressiva sowie anderen Myopathien. Klin. Wschr. 33, 513 (1955).
Schott, J., M. Jacobi, and M. A. Wald: Electrocardiographic patterns in the differential diagnosis of progressive muscular dystrophy. Amer. J. med. Sci. 229, 517 (1955).
Schreiber, G., u. R. Lesch: Zum Verhalten von GOT, GPT, LDH und SDH im Serum unter der Verabreichung von Prednisolon. Med. Klin. 60, 1123 (1965).
Schreyer, K.: Die Hyperaminoazidurien beim Kinde. Pädiat. Grenzgeb. 2, 110 (1963).
Stare, F. J., E. S. Gordon, and M. J. Musser: Effect of succinic acid on the respiration of normal human muscle and various myopathies. Nature (Lond.) 141, 831 (1938).
Stave, U.: Transaminasen und glykolytische Fermente im Serum von Neugeborenen, Säuglingen und Kindern. Z. Kinderheilk. 81, 472 (1958).
Stein, J. M., and H. A. Padykula: Histochemical classification of individual skeletal muscle fibers of the rat. Amer. Anat. J. 110, 103 (1962).
Stephens, J., and E. Lewin: Serum enzyme variations and histological abnormalities in the carrier state in Duchenne dystrophy. J. Neurol. Neurosurg. Psychiat. 28, 104 (1965).
Stern, P.: Neue Ansichten über Dystrophia musculorum progressiva (Erb). Wien. Z. Nervenheilk. 13, 16 (1956).
Stockdale, F. E., and H. Holtzer: DNA synthesis and myogenesis. Exp. Cell Res. 24, 508 (1961).
Storstein, O., and K. Austarheim: Progressive muscular dystrophy of the heart. Acta med. scand. 150, 431 (1955).
Storstein, O. and F. O. Kinge: Heart involvement in progressive muscular dystrophy. Acta psychiat, scand. 36. 489 (1961).
Storstein, O. The heart in progressive muscular dystrophy. Exp. Med. Surg. 22, 13 (1964).
Stroinska-Kusiowa, B.: Radiograms of osseous changes in dystrophia musculorum progressiva. Proc. 8th Int. Congr. Neurology, Vienna 1965, Tom. II, p. 265.
Sttjbbs, S. S. G., and M. C. Blanchaer: Glycogen phosphorylase and glycogen synthetase activity in red and white skeletal muscle of the Guinea pig. Canad. J. Biochem. 43, 463 (1965).
Tada, K., Y. Watanabe, and H. Chikaoka: Demonstration of defect of creatine-phosphokinase in muscle of progressive muscular dystrophy. Tohoku J. exp. Med. 75, 296 (1961).
Takasu, T., and B. P. Hughes: Lactate dehydrogenase isoenzymes in developing human muscle. Nature (Lond.) 212, 609 (1966).
Tallan, H. H.: Free amino acids of muscle of normal and of vitamin E-deficient rabbits. Proc. Soc. exp. Biol. (N. Y.) 89, 553 (1955).
Tammisto, T., and M. Airaksinen: Increase of creatine kinase activity in serum as sign of muscular injury caused by intermittently administered suxamethonium during halothane anaesthesia. Brit. J. Anaesth. 38, 510 (1966).
Tappel, A. L., and H. Zalkin: Inhibition of lipide peroxidation in mitochondria by vitamin E. Arch. Biochem. 80, 333 (1959).
Tappel, A. L., and H. Zalkin, K. A. Caldwell, I. D. Desai, and S. Shibko: Increased lysosomal enzymes in genetic muscular dystrophy. Arch. Biochem. 96, 340 (1962).
Tassoni, J. P., and P. J. Harman: Succinic dehydrogenase and adenosinemonophosphatase activity in dystrophic mouse muscle. Anat. Rec. 136, 289 (1960).
Tassoni, J. P., and P. J. Harman Alterations in succinic dehydrogenase activity at different stages of muscular dystrophy in the mouse. J. Neuropath. exp. Neurol. 20, 158 (1961).
Tassoni, J. P., and P. J. Harman, L. Mantel, and P. J. Harman: Enzymes alterations in muscle cells from mice with hereditary dystrophy. Exp. Cell Res. 35, 219 (1964).
Taussky, H. H., A. Washington, E. Zubillaga, and A. T. Milhorat: Citric acid in tissues of normal and dystrophic animals. Nature (Lond.) 196, 1100 (1962).
Taussky, H. H. Fed. Proc. 22, 318 (1963).
Telford, I. R., G. A. Emerson, and H. M. Evans: Claim for thyroid subnormality in vitamin E low rats. Proc. Soc. exp. Biol. (N. Y.) 38, 623 (1938).
Thompson, M. W., E. G. Murphy, and P. J. McAlpine: An assessment of the creatine kinase test in the detection of carriers of Duchenne muscular dystrophy. J. Pediat. 71, 82 (1967).
Thompson, R. A., and P. J. Vignos: Serum aldolase in muscle disease. Arch. intern. Med. 103, 551 (1959).
Thomson, W. H., P. Leyburn, and J. N. Walton: Serum enzyme activity in musculatur dystrophy. Brit. med. J. 1960, 103 1276.
Thomson, W. H. S.: Sources of error in the biochemical diagnosis of muscular dystrophy. J. Neurol. Neurosurg. Psychiat. 25, 191 (1962).
Tierney, N. A., and J. P. Peters: The mode of excretion of creatine and creatinine in thyroid disease. J. clin. Invest. 22, 595 (1943).
Timme, W.: Progressive muscular dystrophy as an endocrine disease. Arch. intern. Med. 19, 79 (1917).
Tower, D. B., M. A. Pogorelskin, and E. P. Peters: The nature and significance of pentosuria in neuromuscular disease. 7th Ann. Meet. Amer. Acad. Neurol., Dallas 1955.
Taussky, H. H., E. L. Peters, and M. A. Pogorelskin: Nature and significance of pentosuria in neuromuscular disease. Neurology (Minneap.) 6, 37 (1956).
Tsukiyama, K., and K. Ueda: Interrelation between electromyographic and enzymologic findings in skeletal muscles. Electromyography 6, 77 (1966).
Tsvetanova, E., and M. Ognianov: A case of absence of LDH4 in the muscle homogenate from a patient with progressive muscular dystrophy. Clin. chim. Acta 18, 87 (1967).
Tureen, L. L., P. M. Farrell, and R. R. Cova: Comparison of plasma protein changes in antioxidant deficiency muscular dystrophy and genetic muscular dystrophy in the chicken. Proc. Soc. exp. Biol. (N. Y.) 119, 28 (1965).
Tyler, F. H., and G. T. Perkoff: Studies in disorders of muscle. VI. Is progressive muscular dystrophy an endocrine or metabolic disorder? Arch. intern. Med. 88, 175 (1951).
Tyler, F. H. and F. E. Stephens: Studies in disorders of muscle. IV. The clinical manifestations and inheritance of childhood progressive muscular dystrophy. Ann. intern. Med. 35, 169, 1164 (1951).
Uzman, L. L., and H. Rosen: Partition of neuraminic acid among human serum proteins. Science 120, 1031 (1954).
Vallbona, C., G. C. Bagby, W. S. Woodfin, J. Gilliam, and R. E. Carter: Analysis of the QRS vector loop in muscular dystrophy. Cardiovasc. Res. Cent. Bull. 5 I, 5 (1966).
Van Bekkum, D. W., and A. Querido: Inorganic phosphate response to intravenous glucose administration in progressive muscular dystrophy. J. clin. Invest. 32, 1061 (1953).
Vannotti, A., and A. Delachaux: Iron Metabolism and its Clinical Significance. London: J. A. Churchill 1949.
Vannotti, A., J. C. Scholder et M. Jequier: Effets thérapeutiques du cytochrome c dans les myopathies. Schweiz. med. Wschr. 85, 10 (1955).
Vassella, F., R. Richterich, and E. Rossi: The diagnostic value of serum creatine kinase in neuromuscular and muscular disease. Pediatrics 35, 322 (1965).
Veen, J. K. Van Der, and A. F. Willebrands: Isoenzymes of creatine phosphokinase in tissue extracts and in normal and pathological sera. Clin. chim. Acta 13, 312 (1966).
Velez-Garcia, E., P. Hardy, M. Dioso, and G. T. Perkoff: Cysteine-stimulated serum creatine phosphokinase. Unexpected results. J. Lab. clin. Med. 68, 636 (1966).
Vesell, E. S., and A. G. Bearn: Isozymes of lactic dehydrogenase in human tissues. J. clin. Invest, 40, 586 (1961).
Vetter, K., H. Griesche u. K. Moch: Serumfermente und ihr Verhalten unter physiologischen Bedingungen. Z. ges. inn. Med. 16, 359 (1961).
Victor, J.: Metabolic and irritability changes in nutritional myopathy of rabbits and ducks. Amer. J. Physiol. 108, 229 (1934).
Vignos, P. J., Jr., and M. Lefkowitz: A biochemical study of certain skeletal muscle constituents in human progressive muscular dystrophy. J. clin. Invest. 38, 873 (1959).
Vignos, P. J. and J. L. Warner: Glycogen, creatine, and high energy phosphate in human muscle disease. J. Lab. clin. Med. 62, 579 (1963).
Vitetta, M.: Atti Soc. pelorit Sci. fisiche maternat, nat. 7, 373 (1961).
Walton, J. N., and A. L. Latner: Ribosuria in muscular dystrophy. Arch Neurol. (Chic.) 72, 362 (1954).
Walton, J. N. and F. J. Nattrass: On the classification, natural history, and treatment of the myopathies. Brain 77, 169 (1954).
Walton, J. N. The significance of selenium and vitamin E in nutrition. Muscular dystrophy in man. Clinical aspects. Proc. Nutr. Soc. 21, 202 (1962).
Walton, J. N., G. W. Pearce, R. J. Pennington, and D. D. Barwick: Muscular dystrophy. Current research in Newcastle upon Tyne. Rev. canad. Biol. 21, 523 (1962).
Walton, J. N. Muscular dystrophy: Some recent advances in knowledge. Brit. med. J. 1964, 1271, 1344.
Walton, J. N. Some diseases of muscle. Lancet 1964 I, 447.
Walton, J. N. and R. J. T. Pennington: Studies on human muscular dystrophy with particular reference to methods of carrier detection. Ann. N. Y. Acad. Sci. 138, 315 (1966).
Walton, J. N. Dystrophia muscularis progressiva. In: Progressive Muskeldystrophie, Myotonie, Myasthenie. Hrsg. von E. Kuhn. Berlin-Heidelberg-New York: Springer 1966, S. 57.
Warburg, O., u. W. Christian: Gärungsfermente im Blutserum von Tumor-Ratten. Biochem. Z. 314. 399 (1943).
Warlamidis, J., u. O. Ludwig: Herzmuskelbeteiligung bei der Erbschen Krankheit. Wien. Z. inn. Med. 47, 160 (1966).
Watanabe, Y.: Tohoku med. J. 65, 255 (1962).
Watts, D. C.: In: Research in Muscular Dystrophy. London: Pitman 1966.
Watts, D. C. and J. D. Reid: Comparison of protein synthesis in normal and dystrophic mouse muscle. In: Research in Muscular Dystrophy. London: Pitman 1968, p. 336.
Watzka, M.: „Weiße“ und „rote“ Muskeln. Z. mikr.-anat. Forsch. 45, 137 (1933).
Wechsler, I. S., G. G. Mayer, and H. Sobotka: The tocopherol level in human serum during oral tocopherol therapy. Proc. Soc. exp. Biol. (N. Y.) 53, 170 (1943).
Wechsler, W., u. W. Pabelick: Erbliche Muskeldystrophien beim Tier. In: Progressive Muskeldystrophie, Myotonie, Myasthenie. Hrsg. von E. Kuhn. Berlin-Heidelberg-New York: Springer 1966, S. 165.
Weingarten, K.: Primäre Myopathien. Wien. klin. Wschr. 79, 630 (1967).
Weinstock, I. M„ A. D. Goldrich, and A. T. Milhorat: Enzyme studies in muscular dystrophy. I. Muscle proteolytic activity and vitamin E-deficiency. Proc. Soc. exp. Biol. (N. Y.) 88, 257 (1955).
Weinstock, I. Alterations in oxidative metabolism in experimental muscular dystrophy. Amer. J. phys. Med. 34, 320 (1955).
Weinstock, I., A. D. Goldrich, and A. T. Milhorat: Enzyme studies in muscular dystrophy. II. Muscle dipeptidase activity and vitamin E-deficiency. Proc. Soc. exp. Biol. (N. Y.) 91, 302 (1956).
Weinstock, I., S. Epstein, and A. T. Milhorat: Enzyme studies in muscular dystrophy. III. Hereditary muscular dystrophy in mice. Proc. Soc. exp. Biol. (N. Y.) 99, 272 (1958).
Weinstock, I. and M. Lukacs: Enzyme studies in muscular dystrophy. V. Vitamin E-deficiency and denervation atrophy. Enzym. biol. clin. 5, 89 (1965).
Weinstock, I. Enzyme studies in muscular dystrophy. VI. Cathepsin and acid deoxyribonuclease activities during the progression of hereditary muscular dystrophy in the chicken. Enzym. biol. clin. 5, 103 (1965).
Weinstock, I. Comparative biochemistry of myopathies. Ann. N. Y. Acad. Sci. 138, 199 (1966).
Weisenfeld, S., and W. J. Messinger: Cardiac involvement in progressive muscular dystrophy. Amer. Heart J. 43, 170 (1952).
Weissmann, C.: Die Bedeutung der Transaminasen für die interne Diagnostik. Schweiz. med. Wschr. 89, 777, 811 (1959).
Welsh, J. D., T. N. Lynn, and G. R. Haase: Cardiac findings in 73 patients with muscular dystrophy. Arch. intern. Med. 112, 199 (1963).
West, W. T., and E. D. Murphy: Histopathology of hereditary, progressive muscular dystrophy in inbred strain 129 mice. Anat. Rec. 137, 279 (1960).
West, W. T., Meier, H., and W. G. Hoag: Hereditary mouse muscular dystrophy with particular emphasis on pathogenesis and attempts at therapy. Ann. N. Y. Acad. Sci. 138, 4 (1966).
Whedon, D. G., E. Shott, V. Toscani, and E. Stevens: Metabolic studies in paralytic acute anterior poliomyelitis. I. Alterations in nitrogen and creatine metabolism. J. clin. Invest. 36, 942 (1957).
White, A. A., and W. C. Hess: Some alterations in serum enzymes in progressive muscular dystrophy. Proc. Soc. exp. Biol. (N. Y.) 94, 541 (1957).
White, A., P. Handler, D. Smith, and D. W. Stetten: Principles of biochemistry. New York: McGraw-Hill 1959.
White, L. P.: Some enigmas in the comparison of multiple serum enzyme levels. Ann. N. Y. Acad. Sci. 75, 349 (1958).
White, L. P. Serum enzymes. Variations of activity in disease of muscle. Calif. med. J. 90, 1 (1959).
Whorton, C. M., P. C. Hudgins, and J. J. Conners: Abnormal spectrophotometric absorption spectrums of myoglobin in two forms of progressive muscular dystrophy. New Engl. J. Med. 165, 1242 (1961).
Whorton, C. M., P. C. Hudgins, and J. J. Conners and A. S. Nadas: The myoglobin molecule and its possible structural alterations in diseased states of skeletal and cardiac muscle. J. S. C. med. Ass. (Bgham, Ala.) 56, 583 (1963).
Wieme, R. J., and Y. Van Maercke: The fifth (electrophoretically slowest) serum lactic dehydrogenase as an index of liver injury. Ann. N. Y. Acad. Sci. 94, 898 (1961).
Wieme, R. J. and J. E. Herpol: Origin of the lactate dehydrogenase isoenzyme pattern found in the serum of patients having primary muscular dystrophy. Nature (Lond.) 194, 287 (1962).
Wieme, R. J. and M. J. Lauryssens: Lactate dehydrogenase multiplicity in normal and diseased human muscle. Lancet 1962 I, 276.
Wiesmann, U., H. Moser, R. Richterich u. E. Rossi: Progressive Muskeldystrophie. VII. Die Erfassung von Heterozygoten der Duchenne-Muskeldystrophie durch Messung der Serum-Kreatin-Kinase unter lokalisierter Arbeitsbelastung in Anoxie. Klin. Wschr. 43, 1015 (1965).
Wijhe, M. Van, M. C. Blanchaer, and W. R. Jacyk: The oxidation of lactate and α-glycerophosphate by red and white skeletal muscle. J. Histochem. Cytochem. 11, 505 (1963).
Wijhe, M. Van and S. St. George-Stubbs: The distribution of lactate dehydrogenase isozyme in human skeletal muscle fibers. J. Histochem. Cytochem. 12, 608 (1964).
Wilkins, L., and W. Fleischmann: Effects of thyroid on creatine metabolism with a discussion of the mechanism of storage and excretion of creatine bodies. J. clin. Invest. 25, 360 (1946).
Wilkinson, J. H., and W. A. Withycombe: The substrate specificities of the lactate-dehydrogenase isoenzymes of dystrophic muscle. Biochem. J. 93, 11 p (1964).
Williams, J. D., B. M. Ansell, L. Reiffel, C. A. Stone, and R. M. Kark: Electrolyte levels in normal and dystrophic muscle determined by neutron activation. Lancet 1957, 464 25.
Willis, E. D.: Mechanisms of lipid peroxide formation in animal tissues. Biochem. J. 99, 667 (1966).
Wilson, B. W., D. W. Peterson, and A. L. Lilyblade: Free amino acids of developing skeletal musculature of normal and genetically dystrophic chickens. Proc. Soc. exp. Biol. (N. Y.) 119, 104 (1965).
Wilson, K. M., K. A. Evans, and C. O. Carter: Creatine kinase levels in women who carry genes for three types of muscular dystrophy. Brit. med. J. 1965, 750 25.
Wörner, W., u. E. Kuhn: Untersuchungen der Adenosinphosphate im Blut bei myotonischer Dystrophie. Schweiz. med. Wschr. 87, 400 (1959).
Wörner, W. Bedeutung und Grenzen der Bestimmung der Laktatdehydrogenase-Isozyme bei inneren Erkrankungen. Med. Klin. 59, 434 (1964).
Wohlfahrt, G.: Über das Vorkommen verschiedener Arten von Muskelfasern in der Skelettmuskulatur des Menschen und einiger Säugetiere. Acta psychiat. (Kbh.), Suppl. 12, 1 (1937).
Wolf, H. P., G. Forster u. F. Leuthardt: Ein spezifischer optischer Fermenttest zum Nachweis von Parenchymschädigungen der Leber. Helv. physiol. pharmacol. Acta 15, C44 (1957).
Wolfson, R., V. Yakulis, R. D. Coleman, and P. Heller: Studies on fetal myoglobin. J. Lab. clin. Med. 69, 728 (1967).
Wroblewski, F., C. Ross, and K. Gregory: Isoenzymes and myocardial infarction. New Engl. J. Med. 263, 531 (1960).
Wrogmann, K., and M. C. Blanchaer: Oxidative phosphorylation by muscle mitochondria of dystrophic mice. Canad. J. Biochem. 45, 1271 (1967).
Young, H. L., W. Young, and I. S. Edelman: Electrolyte and lipid composition of skeletal and cardiac muscle in mice with hereditary muscular dystrophy. Amer. J. Physiol. 197, 487 (1959).
Young, J. M., and J. S. Dinning: A relationship of vitamin E to nucleic acid metabolism. J. biol. Chem. 193, 743 (1951).
Yudajew, N. A.: Untersuchungen über den Einfluß der Denervation von Muskeln auf deren Gehalt an Carnosin und Anserin bei Anwendung der Verteilungschromatographie. (Russ.) Dokl. Akad. Nauk SSSR (Otd. Biokh.) 67, 1069 (1949).
Zalkin, H., and A. L. Tappel: Studies of the mechanism of vitamin E action. IV. Lipide peroxidation in the vitamin E-deficient rabbit. Arch. Biochem. 88, 113 (1960).
Zalkin, H., K. A. Caldwell, S. Shibko, I. D. Desai, and T. A. Holliday: Increased lysosomal enzymes in muscular dystrophy of vitamin E-deficient rabbits. J. biol. Chem. 237, 2678 (1962).
Zatti, M., F. Rossi, and A. Tartarini: Increased G-6-P dehydrogenase activity in pathological regressive processes of skeletal muscle. Ital. J. Biochem. 11, 418 (1962).
Zatuchni, J., E. E. Aegerter, L. Molthan, and C. R. Shuman: The heart in progressive muscular dystrophy. Circulation 3, 846 (1951).
Zierler, K. L.: Factors which influence movement of aldolase from excised rat diaphragm. Amer. J. Physiol. 183, 675 (1955).
Zierler, K. L. Movement of aldolase from excised rat diaphragm. Amer. J. Physiol. 185, 1 (1956).
Zierler, K. L. Diffusion of aldolase from rat skeletal muscle. Amer. J. Physiol. 190, 201 (1957).
Zierler, K. L. Muscle membrane as a dynamic structure and its permeability to aldolase. Ann. N. Y. Acad. Sci. 75, 227 (1958).
Zierler, K. L. Aldolase leak from muscle of mice with hereditary muscular dystrophy. Bull. Johns Hopk. Hosp. 102, 17 (1958).
Zierler, K. L. Potassium flux and further observations on aldolase flux in dystrophic mouse muscle. Bull. Johns Hopk. Hosp. 108, 208 (1961).
Zundel, W. S., and F. H. Tyler: The muscular dystrophy. New Engl. J. Med. 273, 537, 596 (1965).
Zuppinger, K., R. Richterich u. E. Rossi: Die diagnostische Bedeutung der Heterogenität der Serum-Lactat-Dehydrogenasen. Schweiz. med. Wschr. 92, 198 (1962).
Zymaris, M. C., N. Epstein, A. Saifer, S. M. Aronson, and B. W. Volk: Distribution of acid-soluble nucleotides in hind leg muscles of mice with dystrophia muscularis. Amer. J. Physiol. 196, 1093 (1959).
Zymaris, M. C., A. Saifer, and B. W. Volk: Turnover rates of acid-soluble nucleotides in hind leg muscles of dystrophic mice. Amer. J. Physiol. 203, 475 (1962).
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1969 Springer-Verlag, Berlin · Heidelberg
About this chapter
Cite this chapter
Heyck, H., Laudahn, G. (1969). Die Biochemie der progressiven Muskeldystrophie. In: Die progressiv-dystrophischen Myopathien. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-47429-3_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-47429-3_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-47431-6
Online ISBN: 978-3-642-47429-3
eBook Packages: Springer Book Archive